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PREFACE - SPECIFIC AIMS
Sleep apnea is characterized by a decline in breathing stability, leading to a decrease or
complete cessation of airflow during sleep. The occurrence of adverse breathing events tends to
be cyclical, the severity of which is affected by alterations in chemoreflex properties and upper
airway collapsibility. The accompanying intermittent hypoxia and sleep fragmentation associated
with breathing events has been linked to many cardiovascular, cognitive and metabolic disorders.
Published studies indicate that the severity of breathing events is modulated by an endogenous
circadian rhythm; since the duration and number has been reported to increase from the evening
to the morning, while computer simulations predicted a decrease in such events during daytime
compared to nighttime sleep.
Aim 1 is designed to confirm that the severity of breathing events during sleep is affected
by the time of day. Aim 1 will also investigate if alterations in chemoreflex properties and upper
airway collapsibility are responsible for the alterations in breathing events across the 24 hour
cycle. We hypothesize that the duration and number of breathing events will be greater during
sleep in the morning compared to the afternoon and evening. We also postulate that the critical
closing pressure (i.e. a measure of upper airway collapsibility) and chemoreflex sensitivity will
increase, while the carbon dioxide reserve will decrease in the morning compared to the
afternoon and evening.
If breathing stability and the mechanisms that affect this stability are altered by the time
of day this could impact on therapeutic treatments for obstructive sleep apnea. For example,
continuous positive airway pressure, which is used to treat sleep apnea, could be reduced at
certain times of the day/night if those mechanisms that influence upper airway collapsibility are
affected. Likewise, if other concurrent mechanisms that promote breathing stability are affected
by the time of day this could lead to the development of adjunct therapies that could be used
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independently or alongside continuous positive airway pressure to more effectively eliminate
breathing events. We, and other investigators, have shown that an increase in upper airway
muscle activity is initiated in response to intermittent hypoxia. Increases in upper airway muscle
activity would likely promote stability and contribute to decreasing the severity of apneic events.
Aim 2 will investigate whether the therapeutic continuous positive airway pressure
required to eliminate breathing events varies across the 24 hour cycle. We hypothesize that this
pressure will be highest in the morning as a result of the heightened breathing instability and
lowest during sleep in the afternoon and early evening where the mechanisms promoting
instability are mitigated. In addition, Aim 2 will examine if initiation of respiratory plasticity,
namely long-term facilitation of upper airway muscle activity, following exposure to intermittent
hypoxia impacts the therapeutic pressure and is affected by the time of day. We hypothesize that
long-term facilitation of upper-airway muscle activity will be promoted in the evening and
afternoon in line with the alterations in the aforementioned mechanisms that enhance breathing
stability, and mitigated in the morning where breathing is less stable.
Our findings could provide the rationale for careful determination of therapeutic pressure
during sleep over the day/night cycle. Our results will also establish if other potential novel
adjunct therapies (i.e. intermittent hypoxia) might serve to improve the treatment of sleep apnea.
Lastly, our findings will provide the rationale for altering the administered dose of treatments at
that have recently been proposed to treat sleep apnea at specific time points.
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CHAPTER 1 - INTRODUCTION
Sleep disordered breathing
Sleep serves an important function in many species, including humans; from
physiological maintenance of cells, to memory consolidation and other cognitive functions.
However sleep poses a challenge for the respiratory system. During wakefulness the level of
carbon dioxide and the consequent intracellular pH are the principal stimuli for ventilation (Fink,
1961); however other neural mechanisms also contribute to the maintenance of ventilation
(Longobardo et al., 2002). Environmental factors, including audio and visual stimuli, as well as
mental activity, modulate breathing independent of changes in blood gas levels and
chemoreceptor feedback (Fink, 1961; Shea et al., 1987; Nielsen and Smith, 1952; Mohan and
Duffin, 1997). In contrast, during sleep, breathing is controlled primarily by the carotid body
and central chemoreceptors located in the ventral region of the brainstem. Changes in blood
gases levels detected by these chemoreceptors induce appropriate changes in ventilation to
preserve normal levels (Mateika and Syed, 2013). In addition to the absence of the wakefulness
drive, the activity of upper airway dilator muscles decreases at sleep onset, rendering a narrower
airway with a greater tendency to collapse and create airflow obstruction.
Apnea during sleep is defined by the complete cessation of breathing for a period of at
least 10 seconds. Both apneas and hypopneas (i.e. partial reductions in ventilation) lead to a
decrease in oxygen and an increase in carbon dioxide levels in the blood. The cessation of
airflow can be due to collapse of the upper airway, which is defined as an obstructive apnea, or
the cessation of respiratory motor output from the brainstem, which is characteristic of a central
apnea.

An apnea can also be of mixed nature, which includes a central and obstructive

component (Dempsey et al., 2010). Risk factors for sleep disordered breathing include body
weight, gender, age, and craniofacial structure. Untreated sleep apnea/hypopnea increases the
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risk of fatal and non-fatal cardiovascular events (Marin et al., 2005, Dempsey et al, 2010).
Moreover, disorders linked to insulin resistance and altered neurobehavioral function could be
directly or indirectly linked to sleep apnea; since recurrent exposure to hypoxia, hypercapnia and
sleep disruptions affects many systems and cellular processes (Dempsey et al., 2010). These
processes include activation of pro-inflammatory pathways, increases in reactive oxygen species,
and disruptions in hormonal levels (e.g. leptin and ghrelin). Consequently, obstructive sleep
apnea likely plays a role in the initiation and perpetuation of many disorders.
Mechanisms affecting the severity of sleep disordered breathing
Apneic events tend to occur in a cyclical fashion (Figure 1). At the onset of sleep the
upper airway collapses, leading to an apneic event and subsequent changes in blood gas levels.
The origins of upper airway collapse are two-fold. Isono et al. (1997) observed that the upper

Figure 1. Schematic diagram showing the sequence of events leading to the development of a
central and/or obstructive apnea, and subsequent events that ultimately results in re-establishing
patency of the upper airway. (Mateika and Syed, 2013)
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airway was more collapsible in sleep apnea patients compared to controls in the presence of
complete neuromuscular blockade, which suggests that tissue properties have a role in upper
airway collapsibility. In addition, it was observed in both animal and human models that upper
airway collapsibility is increased during anesthesia or sleep in response to reductions in
neuromuscular activity (Brouillette et al.1979; Seelagy et al. 1994; Patil et al. 2007 and
McGinley et al. 2008). Younes et al. (2003) suggested that one third of apneic events can be
attributed to structural alterations and defects, while the remainder is attributed to neuromuscular
deficits.
Independent of the mechanism, apneic events are usually accompanied by arousal from
sleep which restores airway patency. However, arousal is often associated with increases in
ventilation, which are meant to restore normal blood gases levels, but often exceed metabolic
rate leading to hypocapnia. While such a decrease is not necessarily problematic in the wake
state, it is during sleep. If carbon dioxide decreases below a set point deemed "the apneic
threshold”, a central apnea will occur once sleep is re-established. In addition, the decrease in
carbon dioxide is accompanied by a reduction in upper airway neuromuscular compensation,
since carbon dioxide is an essential stimulus in the modulation of upper airway muscle activity
via the hypoglossal nerve. The cycle then repeats itself multiple times throughout the night
(Mateika and Syed, 2013).
The severity of this cyclical pattern depends upon multiple mechanisms, including, but
not exclusive to, upper airway collapsibility and properties of the chemoreflex response to
changes in blood gases. As seen in Figure 1, reduced neuromuscular compensation will decrease
upper airway patency and promote the occurrence of an apnea.

In addition, heightened

chemoreceptor sensitivity, to decreases in oxygen and increases in carbon dioxide levels that
occur during breathing events, promotes exaggerated levels of ventilation upon arousal which
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increases apneic severity by inducing hypocapnia. Reductions in the carbon dioxide reserve (i.e.
the difference between the carbon dioxide baseline level and the apneic threshold), whether a
consequence of changes in chemoreflex sensitivity, the apneic threshold or baseline carbon
dioxide, promote hypocapnia.
Time of day affects breathing mechanisms
Circadian effect on breathing instability. In addition to apneic events occurring in a
cyclical fashion, the severity of these events, characterized by an increase in number and
duration of events, appears to be affected by the time of day. A number of studies have shown
that breathing events increase in number (Fanfulla et al. 1997) and duration (Cala et al, .1996;
Sforza et al., 1998) during sleep from the beginning to the end of the night independent of sleep
stage. In addition, computer modeling simulations have predicted a reduction in the number of
breathing events during daytime compared to nighttime sleep (Stephenson et al., 2004). If the
results of these small clinical studies are correct then fluctuations in chemoreflex properties (i.e.
chemoreflex sensitivity and a reduction in the carbon dioxide reserve) and mechanisms that
influence upper airway collapsibility across the 24 hour cycle could be responsible for the
reported increases in breathing instability.
This suggestion is supported by the results obtained by Sforza et al. (1998) who showed
that an increase in the duration of breathing events during the night was accompanied by an
increase in respiratory drive, which could be a consequence of enhanced chemoreflex sensitivity.
In addition to these findings, Mahamed et al. (2005) measured chemoreflex sensitivity during
wakefulness before and after 6 hours of sleep in individuals with sleep apnea and reported an
increase in the morning compared to the evening.

Therefore, increases in chemoreflex

sensitivity are evident from the evening to the morning in individuals with sleep apnea.
However, these increases may not be a consequence of time of day per se but rather a
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consequence of confounding factors that are linked to sleep apnea, including intermittent
hypoxia. Indeed, numerous studies have shown that chemoreflex sensitivity increases following
exposure to intermittent hypoxia in both healthy individuals and individuals with sleep apnea.
However, to our knowledge no studies have been designed to determine if alterations in
chemoreflex properties are affected by time of day independent of other confounding factors
associated with sleep apnea. Our preliminary results (see Figure 4 in Chapter 2) suggest that this
is the case, since the carbon dioxide reserve was reduced and chemoreflex sensitivity was
increased in the morning compared to the evening and afternoon, independent of other
confounding factors, in a group of sleep apnea participants that completed a constant routine
protocol. Therefore, Aim 1 of my prospectus is designed in part to confirm that the severity of
sleep apnea is affected by the time of day.

Likewise, aim 1 is designed to determine if

chemoreflex properties are affected by the time of day independent of confounding factors that
normally are linked to breathing instability during sleep.
Moreover, time of day might also affect upper airway muscle function. This suggestion is
supported indirectly from studies (Martin et al. 1999 and Zhang et al. 2009) which reported that
the force and strength of limb muscles are greater in the late afternoon compared to the early
morning, which could be indicative of a circadian rhythm to the control of muscle activity. This
possibility is supported by studies which have shown that serotonin (Agren et al., 1986, Mateos
et al., 2009 and Sun et al., 2002), brain derived neurotrophic factor (BDNF) and phosphorylated
extracellular regulated kinases (Serchov and Heumann, 2006), which all have a role in
modulating hypoglossal motor neuron activity, are regulated by a circadian rhythm. In addition,
5-HT2A receptor mRNA levels in rats differ between two time points, being higher at the onset of
the active phase (6–7 pm) compared to the onset of the rest period (8–9 am) (Volgin et al. 2013).
To my knowledge, no studies have examined the variation in upper airway collapsibility across
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the 24 cycle. However, our preliminary data (see Figure 6 in Chapter 2) indicates that the active
critical closing pressure of the upper airway, which is an indicator of the neuromuscular
contribution to maintaining airway patency, is more positive (i.e. more collapsible) in the
morning compared to the evening and afternoon.
Therefore, Aim 1 will also examine if passive tissue and neuromuscular properties that
influence airway patency is affected by the time of day in individuals with sleep apnea.
Collectively, we hypothesize that the severity of apneic events will be greater in the morning
compared to the afternoon and evening. Moreover, we hypothesize that chemoreflex sensitivity
will be greater, the carbon dioxide reserve will be reduced and the airway will be more
collapsible in the morning compared to the afternoon or evening sleep.
Respiratory plasticity
Increases or decreases in neuronal activity can strengthen or weaken connections as well
as activating de novo and/or pre-existing neuronal pathways that have been quiescent. This
phenomenon is often referred to as synaptic plasticity. Forms of synaptic plasticity include
respiratory long-term facilitation which is characterized by a progressive increase in respiratory
motor output during normoxic periods after exposure to intermittent hypoxia, and progressive
augmentation which is characterized by enhancement of the hypoxic ventilatory response
(Mateika and Syed, 2013).
Long-term facilitation is initiated by intermittent but not sustained hypoxia (Figure 2).
Single hypoxic episodes that are brief can lead to acute increases in respiratory motor output that
return to baseline levels within minutes following the hypoxic episode. However, successive
episodes (i.e. intermittent hypoxia) lead to sustained respiratory motor output for up to 90
minutes following the final hypoxic episode (Figure 2) (Baker and Mitchell, 2000; Mitchell et
al., 2001).
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Figure
2.
Integrated
phrenic discharge in one
rat exposed to episodic
hypoxia and one rat
exposed to 20 min
continuous
hypoxia.
Integrated
phrenic
discharge during baseline,
hypoxia, and 15, 30 and 60
min post-hypoxia. Note
that
only intermittent
hypoxia elicited LTF.
(Baker and Mitchell, 2000)
This phenomenon is governed by cellular mechanisms that respond differently to changes
in the intensity of administered hypoxia. Exposure to moderate acute intermittent hypoxia leads
to the release of serotonin at the level of spinal respiratory motoneurons. The binding of
serotonin to 5-HT2 receptors leads to production of brain derived neurotrophic factor, activation
of TrkB receptor and ERK-MAPK signaling that results in facilitation of the input to the
respiratory motor neuron (Figure 3a). Also contributing to this pathway is the production of
reactive oxygen species by NADPH oxidase which inhibits protein phosphatases and leads to
activation of PKC and production of BDNF. This pathway is referred to as the Q pathway since
it involves activation of the Gq protein coupled to the 5-HT2 receptor. In response to exposure to
severe intermittent hypoxia (Figure 3a), there is accumulation of extracellular adenosine which
activates adenosine 2A receptors and consequently TrkB and Akt, with eventual facilitation of
the motor input. This pathway is deemed the S pathway since it involves activation of the the Gs
protein coupled to the adenosine 2A receptor. Under conditions of severe hypoxia the S pathway
may exert an inhibitory effect on the Q pathway thereby dominating the control of the response.
This cross talk between the 2 pathways allows for great flexibility in the system and the ability to
express different forms of plasticity in response to different conditions.
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Figure 3a. Cellular pathways involved in
phrenic motor long term facilitation
following acute intermittent hypoxia. (A)
The Gq protein–coupled 5-HT2 receptor is
activated leading to PKC activation and
synthesis of brain derived neurotrophic
factor. The activation of TrkB by BDNF
phosphorylates ERK, thereby facilitating
input to the motor neuron. (B) The Gs
protein–coupled adenosine 2A (A2A)
receptor is activated, leading to a cascade
of PKA, TrkB and Akt activation. The
result is the facilitation of respiratory
motoneuron input. (DeVinney et al., 2013)

Long-term facilitation of ventilation and genioglossus muscle activity have been
documented in healthy humans and humans with obstructive sleep apnea during both
wakefulness and sleep. We have shown in our laboratory that this phenomenon is exquisitely
dependent on carbon dioxide levels. In other words, long-term facilitation manifests itself when
carbon dioxide is sustained slightly above baseline levels but is not evident when carbon dioxide
levels are not controlled and hypocapnia ensues. The presence of this phenomenon in humans is
exciting because it may ultimately lead to the development of adjunctive therapies to treat
obstructive sleep apnea.
Presently, the most common treatment for sleep apnea is continuous positive airway
pressure. The positive pressure serves as a splint to maintain airway patency, thereby relieving
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airflow obstruction. However, there are multiple side effects associated with this treatment
modality that has resulted in limited compliance. The lack of compliance in some cases may be
a consequence of elevated levels of positive pressure that are required to maintain airway
patency. Thus, adjunctive therapies that contribute to reducing the effective positive airway
pressure may ultimately lead to improved compliance. Recognition that stability of the upper
airway is influenced by the time of day (see above Specific Aim 1) may lead to careful
determination of therapeutic positive pressure values during sleep at different times across the 24
hour cycle. Moreover, if long-term facilitation of genioglossus muscle activity can be initiated in
individuals with sleep apnea this phenomenon may serve to reduce the effective therapeutic
pressure to treat sleep apnea at a given point in the 24 hour cycle. More interestingly, if this
form of respiratory plasticity is affected by the time of day, its influence may be more effective
at certain points throughout the day/night cycle.
As a result, Aim 2 is designed to determine if the continuous positive airway pressure
required to eliminate breathing events varies across the 24 hour cycle, hence significantly
impacting the therapeutic approach to the treatment of sleep apnea. Aim 2 will also determine if
long-term facilitation of upper airway muscle activity influence levels of therapeutic positive
airway pressure and whether this influence is variable and dependent on the time of day.
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CHAPTER 2 - TIME OF DAY AFFECTS THE FREQUENCY AND
DURATION OF BREATHING EVENTS AND THE CRITICAL CLOSING
PRESSURE DURING NREM SLEEP IN PARTICIPANTS WITH SLEEP APNEA
(This chapter contains previously published material. See Appendix B)

Introduction
Clinical studies have reported that independent of sleep stage and body position, the
number (Fanfulla et al., 1997;Sforza et al., 1998) and duration (Cala et al., 1996;Charbonneau et
al., 1994;Lavie et al., 1981;Montserrat et al., 1996a;Sforza et al., 1998) of breathing events
increase throughout the night during non-rapid eye movement sleep; although to our knowledge
no studies have examined if these differences manifest in a similar manner in stages N1 and N2
of non-rapid eye movement sleep.

Likewise, computer simulations have suggested that a

reduction in the apnea-hypopnea index during daytime compared to nighttime sleep may occur
(Stephenson, 2004). This latter postulation has been reported in a small number of hypertensive
men, although other confounding factors may have influenced the findings (Scharf et al., 1990).
The potential mechanisms underlying the increase in the number and duration of
breathing events across a 24-hr period are likely multifactorial and phenotypically dependent.
One possibility is that increases in chemoreflex sensitivity, coupled to a reduction in the carbon
dioxide reserve contribute to the progressive increase in breathing events across the night (see
Chapter 3 for the detailed findings) (El-Chami et al., 2014a;Mateika & Narwani, 2009;Mateika
& Sandhu, 2011;Mateika & Syed, 2013a;Mateika, 2015;Mateika et al., 2015). This possibility is
well founded in that enhanced chemoreflex sensitivity promotes the occurrence of both central
and obstructive breathing events (Dempsey et al., 2004;Dempsey, 2005;Dempsey et al.,
2010;Yokhana et al., 2012).

The results from many studies indicate that the increase in

chemoreflex sensitivity across the night could be the result of exposure to intermittent hypoxia, a
hallmark of sleep apnea (Chowdhuri et al., 2010;Gerst, III et al., 2011;Griffin et al.,
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2012;Khodadadeh et al., 2006;Mateika et al., 2004a;Wadhwa et al., 2008).

However, we

showed that increases in chemoreflex sensitivity and decreases in the carbon dioxide reserve
were evident during sleep in the morning compared to the evening and afternoon; independent of
physiological hallmarks typically associated with sleep apnea (i.e. intermittent hypoxia and sleep
fragmentation) (El-Chami et al., 2014a).
Previous studies have also addressed if increases in the arousal threshold or effective
recruitment threshold of upper airway muscles are responsible for reported increases in apnea
duration from the beginning to the end of the night. Based on a series of studies, a number of
investigators (Berry et al., 1995;Cala et al., 1996;Montserrat et al., 1996a) proposed that
inflammation, edema, neural damage in response to snoring related vibrations, and forceful
collapse of the larynx progressively dampen excitatory inputs from upper airway sensory
receptors from the beginning to the end of the night, leading to alterations in the arousal and/or
effective recruitment threshold. Thus, the effect of time of day on the arousal and/or effective
recruitment threshold was linked to factors that are a consequence of apnea and not
endogenously modulated by a circadian rhythm. Traumatization of the upper airway could also
account for increases in frequency of apnea events since collapsibility of the upper airway could
be impacted by upper airway muscle fatigue associated with exposure to intermittent hypoxia
(Bradford et al., 2005;McGuire et al., 2002;Ray et al., 2007) and dampening of excitatory
sensory inputs from the upper airway receptors (Cala et al., 1996).
Despite these findings, we were interested in determining if alterations in upper airway
collapsibility occur in accordance with the time of day, independent of deleterious factors
typically associated with sleep apnea. To our knowledge no studies have directly examined the
effect of time of day on upper airway muscle collapsibility in humans with sleep apnea.
Nevertheless, existing evidence indicates that upper airway collapsibility, via modulation of

12
neuromuscular properties, could be affected by the time of day. Many studies in humans [see
(Zhang et al., 2009) for review] have shown that force, along with other measures of muscle
function [i.e. rate of tension development and one-half relaxation time (Martin et al., 1999)], in
skeletal muscle ranging from the abductor pollicus (Martin et al., 1999) to leg extensor muscles
(Sedliak et al., 2008), are enhanced in the late afternoon and evening compared to the early
morning.

In addition, studies in other animals have reported that the concentration of a

neuromodulator involved in the control of upper airway muscle activity (i.e. serotonin) along
with receptor sub-types (i.e. 5HT2A) are modulated by the time of day (Agren et al., 1986;Mateos
et al., 2009;Sun et al., 2002;Volgin et al., 2013).
Therefore, the primary aims of the present investigation were two-fold.

First, we

examined the effect of time of day on the duration and frequency of breathing events during nonrapid eye movement sleep in the evening, morning and afternoon in individuals with sleep apnea
using a constant routine protocol. This aim was completed to confirm the results from previous
clinical studies and to add to these findings by exploring the characteristics of breathing events
during N1 and N2 sleep at three time periods throughout the 24 hour cycle. We hypothesized
that the duration and frequency of breathing events would be greater during sleep in the morning
compared to the evening and afternoon. The second aim of the study was to examine if
collapsibility of the upper airway, via measures of the critical closing pressure, was altered when
these measures were compared during non-rapid eye movement sleep in the evening, morning
and afternoon. We hypothesized that the critical closing pressure would be more positive in the
morning compared to the evening and afternoon, if the modulation of upper airway muscle
function is similar to that reported previously for other skeletal muscles.
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Methods
Protocol
The Human Investigation Committees of Wayne State University School of Medicine
and John D. Dingell Veterans Affairs Medical Center approved the experimental protocol.
Thirteen male participants with untreated pure or predominantly obstructive sleep apnea, but no
other comorbidities (e.g., heart and lung disease, hypertension, and obesity), completed the
protocol. All the participants who completed the protocol visited the laboratory on six occasions
(Figure 3). During the first visit to the laboratory, written informed consent was obtained and
thereafter a physical examination, health and lifestyle questionnaires, blood pressure, lung

Figure 3. A schematic diagram showing the protocol completed by the participants. * - 8 of 13
participants completed visit 7.
volume measures, and a 12-lead ECG were completed. After ensuring that the inclusion criteria
were met, participants completed a baseline nocturnal polysomnogram to confirm the presence
of obstructive sleep apnea (visit 2). Upon verification, participants were enrolled in the protocol
and their sleep was monitored at home for 2 weeks, using an actigraph watch (Actiwatch
Spectrum, Philips Respironics, Murraysville, PA), before obtaining the planned physiological
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measurements on visits 4–6 (see subsequent paragraph for further details). During the two week
time period we requested that the participants adhere to a regular sleep-wake schedule with a
sleep onset time between 10–11 pm and a wake time of 7–8 am. We also requested that the
participants avoid daytime napping. During this time period the participants returned to the
laboratory (i.e. Visit 3) to determine the therapeutic continuous positive airway pressure required
to maintain airway patency. In addition, a “practice trial” using the methodology and procedures
required to determine the critical closing pressure was completed so that each participant was
accustomed to the procedures.
After the 2 week time period, participants returned to the laboratory on three separate
occasions (i.e., visits 4 –6). Each visit was separated by a minimum of seven days. Participants
maintained a regular sleep-wake schedule, which was monitored with the actigraph watch, and
were not treated with continuous positive airway pressure during the seven day interval that
separated each visit. Participants were asked to abstain from alcohol and caffeinated beverages
at least one day prior to the visit. On the day of each study, participants arrived at the laboratory
at approximately 8:00 PM.

Upon arrival, the participants ingested a radiotelemetry pellet

(CorTemp Sensor, Palmetto, FL) which measured core body temperature every 10 s throughout
each visit. This measure was used to establish the nadir of core body temperature. Following
instrumentation, the participants completed a constant routine protocol.

The protocol was

comprised of sleep sessions in the evening, morning and afternoon that were 3 hours in duration
(i.e., 10 PM – 1 AM, 6 – 9 AM, and 2 – 5 PM). Subsequent to the evening and morning sleep
sessions, participants were placed in a semi-recumbent position during wakefulness. At the
onset of each wake session, participants watched a movie for ∼ 120 min and immediately
thereafter read for ∼ 90 min. Ninety minutes before the morning or afternoon sleep session, the
participants sat quietly and did not engage in any activity.

During each wake session,
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participants received small snacks every 95 min composed of ∼ 15% fat, 75% carbohydrate, and
10% protein. Moreover, participants received up to a maximum of 1 liter of water over the
length of the constant routine protocol. During wakefulness, the participants were in a dimly lit
(i.e., 30 lux) laboratory that was separated from sunlight and external cues including phones,
clocks, radios, and television. The laboratory temperature was controlled at 22–23°C.
Interventions and procedures
During the 4th visit, breathing events (i.e. apneas and hypopneas) were measured during
each sleep session. Measures of breathing events were obtained from 12 of 13 participants. One
participant expressed a desire to withdraw from the study because of time constraints.
Consequently, we chose to obtain measures of the critical closing pressure (Figure 4) rather than
measures of breathing events, prior to withdrawal.

On the 5th and 6th visits, which were

randomized, chemoreflex properties (i.e., chemoreflex threshold, sensitivity and the carbon
dioxide reserve) or the upper airway critical closing pressure was measured during each sleep
session in 10 participants. A description of the methods used to measure the chemoreflex
properties, and the results which demonstrated the effect of time of day on these properties can
be found in Chapter 3, in addition to being published previously (El-Chami et al., 2014a).
Subsequent to this publication, 3 additional participants were enrolled, so that measures of the
critical closing pressure were obtained from thirteen participants.
In order to assess upper airway collapsibility, the critical closing pressure (i.e., the
pressure associated with collapse of the upper airway) was measured during each sleep session
(Figure 4). During each session, airway patency was initially maintained using a holding
pressure that was 1.7 ± 0.5 cmH2O less than the therapeutic pressure determined during visit 3.
The holding pressure generated a reduction in airflow of 10–15% and was employed to prevent
over-distension of the airway. Measurement of the critical closing pressure was performed by
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reducing the mask pressure in a stepwise fashion, by increments of 1-2 cmH2O (Pcrit 3000,
version 1.0, Philips Respironics, Murrysville, PA) for a duration of 3 to 5 breaths. Each step
down in pressure was separated by a 1 minute recovery period at the holding pressure. Stepwise
reductions in pressure continued until the airway was fully collapsed, which was defined by
measures of airflow less than 10% percent of baseline.

Figure 4. An illustration of the data collection procedures used to determine the critical closing
pressure that demarcated collapse of the upper airway. Continuous positive airway pressure was
decreased in a step wise fashion. The duration of each step was 3 to 5 breaths and was separated
by the return to a holding pressure for 1 minute. Step wise decreases were administered until
flow was abolished (i.e. apnea) and the corresponding pressure was ascertained.
We were also interested in determining if measures of the critical closing pressure were
similar at a given time of day using a well-established method (McGinley et al., 2008a)
characterized by consecutive 1-2 cmH2O reductions in mask pressure, which were sustained for a
duration of 5 minutes and were not separated by a recovery period at the holding pressure. We
rationalized that establishing a holding pressure prior to a step-down in mask pressure lasting 3-5
breaths would be accompanied by upper airway muscle activity. Moreover, we considered that
reductions in airway pressure are detected in a short period of time and result in the activation of
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the upper airway muscles within 50 ms (Horner et al., 1991;Horner et al., 1994). Consequently,
we hypothesized that independent of the length of time maintained after a step down in pressure
the critical closing pressure that demarcated collapse of the airway would be similar.

If

supported, our findings would provide a rationale for using the method with step downs in
pressure of short duration, because the overall time required to implement the methodology
would be shorter and decrease the probability of disrupting sleep architecture. In order to
compare the two methods used to measure the critical closing pressure, 8 of the 13 participants
returned to the laboratory for an additional visit (Figure 3 – visit 7). During this visit we
measured the critical closing pressure during sleep in the evening, morning and afternoon using
the method characterized by step downs in mask pressure which were sustained for 5 minutes
(McGinley et al., 2008a).
Instrumentation
During the sleep studies the monitoring montage included an electroencephalogram
(C3/A2, C4/A1, O1/A2, O2/A1), electrooculograms, submental electromyogram, and an
electrocardiogram.

Chest wall and abdominal movements were measured using inductive

plethysmography (Respitrace, Ambulatory Monitoring, Ardsley, NY).

Airflow and breath

timing (inspiratory and expiratory time) were measured using a pneumotachometer (model
RSS100-HR, Hans Rudolph, Shawnee, KS) attached to a nasal mask. Oxygen saturation (arterial
O2 saturation) was measured with a pulse oximeter (Biox 3700; Ohmeda, Boulder, CO).
Measures of end-tidal oxygen (Model 17515, Vacumed, Ventura, CA) and end-tidal carbon
dioxide (Model 17518, Vacumed, Ventura, CA) were obtained from air expired into sampling
tubes attached to ports on the nasal mask. Mask pressure was measured using a pressure
transducer attached via tubing to a port on the nasal mask. Upper airway pressure was measured
using a transducer tipped catheter (Mikro-Cath 825-0101, Millar, Houston, TX) to confirm apnea
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and ascertain the presence of flow limitation.

All physiological variables were analog to

digitally converted at a sampling frequency of 100 Hz/channel and input into a computer using a
commercially available software package (gamma version 4.0, Astro-Med, West Warwick, RI).
The cardiorespiratory variables were also input into a second computer using a commercially
available software package (WinDaq, Dataq Instruments, Akron, OH).
Data analysis
All polysomnography studies were analyzed for sleep stage, arousals, and respiratoryrelated events according to standard published criteria (Iber C et al., 2007).

An event

characterized by the absence of inspiratory airflow for a minimum of 10 s was identified as an
apnea. A hypopnea was defined as an event accompanied by a > 50% reduction in airflow that
lasted for a minimum of 10 s and was also accompanied by either an arousal or a ≥ 3% reduction
in oxygen saturation in the absence of an arousal. During the 4th visit, the number and duration
of apneas and hypopneas, as well as, the decrease in oxygen saturation during each event were
determined for N1 and N2 of non-rapid eye movement sleep for each sleep session. Analyses of
events recorded in N3 were not included in the results because the overall time spent in N3 was
not sufficient to make adequate comparisons between sleep sessions within or across participants
(see Table 2).
For each participant, baseline measures of minute ventilation and the partial pressure of
end-tidal carbon dioxide were obtained initially from a 2 minute period of stable non-rapid eye
movement sleep prior to completing the protocol on visit 5 or 6. Baseline measures for 10 of the
13 participants were published previously (El-Chami et al., 2014a). To obtain measures of the
critical closing pressure in 13 participants, baseline values of airflow and mask pressure were
determined initially using the last 5 breaths measured at the holding pressure prior to the initial
step down (Figure 4). Thereafter, with every reduction in pressure the resultant peak flow was
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determined from the second or third breath. The breath selected displayed the greatest limitation
in airflow (Figure 4). In order to obtain the critical closing pressure using the method that
incorporated pressure step-downs of longer duration (n = 8 participants), breath by breath
measures of airflow recorded from the last 2 minutes of the baseline holding period were
analyzed. Thereafter, flow was measured from breaths recorded during the final 2 minutes of
each pressure step down to determine the critical closing pressure. If participants aroused from
sleep prior to determining the critical closing pressure during this visit, this measure was
extrapolated using a second-order polynomial regression from the available pressure steps
recorded prior to arousal. All measures of the critical closing pressure were obtained during
stable N2 of non-rapid eye movement sleep.
We were interested in determining the correlation between the critical closing pressure
and baseline measures of the apnea/hypopnea index. To examine this relationship we averaged
the critical closing pressures measured in the evening, morning and afternoon. In addition, to
determine the correlation between the partial pressure of end-tidal carbon dioxide and the critical
closing pressure we averaged values of end-tidal carbon dioxide, and averaged the critical
closing pressure, measured in the evening, morning and afternoon. To further explore this
relationship, we also averaged end-tidal carbon dioxide and critical closing pressure values in the
evening and afternoon, since measures of the critical closing pressure were similar for these two
sessions. Subsequently, the change in end-tidal carbon dioxide and critical closing pressure in
the morning compared to the average of the evening/afternoon was determined in order to
correlate these measures.
Measurements of core body temperature were purified to eliminate small fluctuations in
temperature associated with movements during wakefulness that occurred during feeding or
bathroom breaks. Thereafter, the temperature was fit with a cosine wave:
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[y = m + a cos (2πt/ω) + ϕ]
where y is the temperature, m is the circadian rhythm adjusted mean (i.e., mesor), a is the
amplitude of the circadian rhythm, t is time (hours), ω is the period of the circadian rhythm, and
ϕ is the phase angle. Once the phase and period of the core body temperature were established
for an individual, this information was used to assign a circadian phase (from 0 to 359°) to each
minute, with 0° corresponding to the minimum of the waveform fitted to the core body
temperature data. The plotted data were then used to determine the session that corresponded to
the core body temperature nadir.
Statistical analysis
A one-way repeated-measures analysis of variance in conjunction with Fisher’s least
square difference post hoc test was used to compare sleep efficiency measures in the evening,
morning and afternoon. A similar analysis was used to compare the measures of the critical
closing pressure (n = 13) and baseline measures of carbon dioxide in the evening, morning and
afternoon. A Kruskal-Wallis one way analysis of variance on ranks combined with StudentNewman-Keuls post hoc test was used to compare event duration in participants that experienced
either an increase or a decrease in event frequency during N2. A similar analysis was used to
compare the partial pressure of end-tidal carbon dioxide in the evening, morning and afternoon.
A two-way repeated measures analysis of variance in conjunction with Fisher’s least square
difference post hoc test was used to compare the percentage of time spent in N1 and N2 of nonrapid eye movement sleep during the evening, morning, and afternoon sleep sessions. The two
factors in the analysis were sleep stage (i.e. N1 and N2) and time of day (i.e. evening, morning
and afternoon). A similar analysis was used to compare measures of breathing event duration,
apnea/hypopnea indices, decreases in oxygen saturation and the critical closing pressure
measured using two separate methods. For each variable, the factors used in the analysis were
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sleep stage and time of day, with the exception of the statistical analysis of the critical closing
pressure. In this case, the factors were time of day and method (i.e. brief or prolonged stepdowns in pressure) used to determine the critical closing pressure.

A Pearson correlation

analysis was used to determine if i) the critical closing pressure was correlated to the baseline
apnea/hypopnea index ii) the average baseline measures of end-tidal carbon dioxide were
correlated to the average critical closing pressure measured during the evening, morning and
afternoon; iii) the change in the partial pressure of end-tidal carbon dioxide was correlated to the
change in the critical closing pressure from the morning to the evening and afternoon. Data are
presented as means ± S.E. A P value ≤ 0.05 was considered statistically significant.
Results
Table 1 shows the anthropometric variables obtained for the group. Collectively, the
participants were young to middle age, and not obese, as indicated by the body mass index. The
apnea/hypopnea index determined from the screening sleep study (i.e. Visit 2) ranged from mild
to severe according to standard criteria. The level of oxygen desaturation achieved during
apneic/hypopneic events was mild even in those participants considered to have severe sleep
apnea. Systolic and diastolic blood pressure measurements were within normal limits and the
Epworth sleepiness scale indicated a history of mild sleepiness (Table 1). The average
Table 1. Baseline anthropometric, blood pressure and sleep measures
Variable
Age, yr.
Height, cm
Weight, kg
Body mass index, kg/m2
Systolic pressure, mmHg
Diastolic pressure, mmHg
Epworth Sleepiness Scale
Apnea/hypopnea index, events/hr
Lowest oxygen desaturation during apnea, %
Race
Values are means ± SE

29.5 ± 1.9
174.5 ± 4.0
82.6 ± 2.7
26.4 ± 0.6
119.2 ± 2.6
72.7 ± 2.8
10.0 ± 1.0
41.8 ± 4.7
87.2 ± 1.2
7 AA, 4 Caucasian, 1 Asian, 1 Indian
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therapeutic pressure required to eliminate apnea during sleep on visit 3 in the OSA participants
was 11.2 ± 0.8 cmH2O. Average measures of core body temperature, recorded during visit 4 of
the protocol, are shown in Figure 5. The nadir of temperature was evident in the early morning
during visit 4 (Figure 5) and in the course of the visit used to measure the critical closing
pressure.

Figure 5. Average values of core body temperature in 12 participants with sleep apnea shown in
30 minute increments over a 24 hour cycle. Note that the nadir in temperature occurred at 6 am
and the peak at 7:30 pm. Zero time represents the onset of the temperature recording (9:00 p.m.).
During visit 4, the participants spent 73.4 ± 4.9 %, 78.0 ± 2.7 % and 71.4 ± 3.6 %, of the
total session time (i.e. 3 hours) in N1 and N2 of non-rapid eye movement sleep in the evening,
morning and afternoon , respectively (P ≥ 0.47). The percentage of time spent in N1 or N2 for a
given 3-hour sleep session was not significantly different between the evening, morning and
afternoon (Table 2) (P ≥ 0.85). Figure 6A shows the average duration of breathing events during
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Table 2. Time spent in a given stage of sleep as a percentage of session time
Wake (%)
N1 (%)
N2 (%)
N3 (%)
REM (%)

Evening
24.7 ± 5.1
22.7 ± 3.7
47.6 ± 3.4
3.1 ± 1.6
1.9 ± 0.9

Morning
9.3 ± 2.3
19.2 ± 2.8
53.0 ± 4.0
5.8 ± 2.5
12.6 ± 2.9

Afternoon
19.9 ± 3.8
20.3 ± 2.5
49.0 ± 3.7
2.1 ± 1.1
8.7 ± 2.8

Values are means ± SE. REM – Rapid Eye Movement Sleep.

N1 and N2 of non-rapid eye movement sleep during the sleep sessions completed on visit 4. The
duration of breathing events was greater in the morning compared to the afternoon and evening
in N1 and N2 of non-rapid eye movement sleep (P  0.001). In addition, the duration of
breathing events was greater during N2 compared to N1 in the evening, morning and afternoon
(P  0.001).

Figure 6. Histograms which show the
mean values for (A) the duration of
breathing events (B) the apnea hypopnea
index and (C) the decrease in oxygen
saturation, for N1 and N2 of non-rapid eye
movement sleep in the evening, morning
and afternoon sleep sessions. Note that
breathing event frequency was greater in
the morning compared to the afternoon
and evening in N1 and the duration of
breathing events was greater in the
morning in both N1 and N2. Also note that
the decrease in oxygen saturation was
similar and independent of breathing event
duration. (*) significantly different from
the
evening
and
afternoon.
(‡)
significantly different from N1.
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The apnea/hypopnea index was greater in the morning compared to the evening (P 
0.01) and afternoon (P  0.02) in N1 of non-rapid eye movement sleep (Figure 6B). In contrast,
the apnea/hypopnea index during the evening, morning and afternoon were similar across the 3
sleep sessions in N2 (Figure 6B). Further examination of the data revealed that an increase in
event frequency was evident in 6 participants, while a decrease was evident in the remaining
participants, in the morning compared to evening. The decrease in event frequency was coupled
to a longer event duration compared to the values associated with increases in event frequency
(30.3 ± 2.8 vs. 22.8 ± 3.3 s; P  0.04).
The apnea/hypopnea index measured during N2 was greater compared to N1 during the
evening (P  0.02) and afternoon sleep sessions (P  0.04). This difference was not evident
throughout the morning sleep session. Baseline oxygen saturation measures were similar across
sleep sessions in N1 (evening – 98 ± 0.3 %; morning – 99 ± 0.2 % and afternoon – 99 ± 0.2 %)
and N2 (evening – 98 ± 0.3 %; morning – 98 ± 0.2 % and afternoon – 98 ± 0.3 %). In addition,
the decrease in oxygen saturation during breathing events was similar in the morning compared
to the afternoon and evening in N1 and N2 (Figure 6C). The decrease in oxygen saturation
during breathing events in N2 was significantly greater compared to N1 independent of the time
of day (P  0.002).
The critical closing pressure using brief step-downs in pressure (i.e. 3-5 breaths) was
more positive in the morning compared to the evening (p  0.02) and afternoon (P  0.01) (n=13)
(Figure 7A). These relationships were unchanged (P  0.001) when the critical closing pressure
was determined using pressure step-downs of longer duration (n=8) (Figure 7B – right side). No
difference in the critical closing pressure was evident in the evening, morning or afternoon when
measures obtained from 8 participants using pressure step-downs of short (3 breaths) and long (5
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minutes) duration were compared (Figure 7B).

The average critical closing pressure was

correlated to the baseline apnea/hypopnea index (r = 0.60, p  0.03; r = 0.74, p  0.01 with one
outlier removed – see Figure 8A for additional details).
Figure 7. Histograms which
show the mean critical closing
pressure in the evening, morning
and afternoon measured using
(A) brief step-downs in pressure
for 3-5 breaths (n=13) and (B)
step-downs in pressure lasting 35 breaths and 5 minutes (n=8).
Note that independent of the
duration of each step-down in
pressure, the critical closing
pressure that demarcated the
upper airway collapsibility was
greater in the morning compared
to the evening and afternoon.
(*) – significantly different from
the evening and afternoon.
PCRIT – critical closing
pressure.

As previously reported for 10 of the 13 participants, baseline measures of the partial
pressure of end-tidal carbon dioxide were lowest in the morning compared to the evening and
afternoon (El-Chami et al., 2014a). This relationship remained unchanged with data from 3
additional participants included (evening 41.4 ± 0.6 vs. morning 40.2 ± 0.4 vs. afternoon 40.6 ±
0.5 mmHg; P  0.01). Interestingly, average baseline measures of the partial pressure of end-
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tidal carbon dioxide were correlated to the average of the critical closing pressure obtained from
the 3 sleep sessions (r = - 0.59, P  0.04). The highest baseline levels of PETCO2 were coupled to
a less positive or negative critical closing pressure and vice versa. In addition, the change in
carbon dioxide in the morning, relative to the average value measured in the evening and
afternoon, were strongly correlated to the change in critical closing pressure in the morning (r = 0.73, P  0.005) (Figure 8B). The greater the decrease in baseline partial pressure of carbon
dioxide the greater the increase in the critical closing pressure and vice versa.
Figure 8. (A) A scatterplot which
shows the relationship between the
average critical closing pressure,
measured in the morning, evening
and afternoon for each participant,
and the baseline apnea/hypopnea
index. Note that the open circle
represents a value that was
significantly outside of the 99 %
confidence intervals shown on the
plot. (B) A scatterplot which shows
the correlation between the change
in carbon dioxide in the morning
compared to measures in the
evening and afternoon, and the
change in the critical closing
pressure in the morning compared
to values measured in the evening
and afternoon.

Discussion
In the present investigation we employed a constant routine protocol to measure the
characteristics of breathing events on one occasion, and the critical closing pressure on another,
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during non-rapid eye movement sleep in the evening, morning and afternoon in participants with
sleep apnea. Our primary findings revealed that the duration of breathing events increased
during N1 and N2 of non-rapid eye movement sleep in the morning compared to the evening and
afternoon. Additionally, an increase in the frequency of breathing events was evident during N1
in the morning. Our results also showed that the critical closing pressure of the upper airway
was more positive in the morning compared to the evening and afternoon. Secondarily, we also
showed that the duration and frequency of breathing events was greater in N2 compared to N1,
and that measures of the critical closing pressure were independent of the duration of the
reduction in pressure used to obtain these measures.
Methodology
Our participants did not suffer from other comorbid conditions (i.e., diabetes,
cardiovascular disease, and obesity). Thus, the potential influence of these comorbidities on the
critical closing pressure was controlled. On the other hand, our results may not be representative
of the responses of older, obese patients who suffer from comorbid conditions. Accordingly, the
effect of time of day on the critical closing pressure could vary and be dependent on age and the
presence of co-morbidities. In addition, our study was limited to investigating the effect of time
of day on the critical closing pressure in men. Inclusion in the study was not limited to this sex;
rather it was by happenstance that the participants available to complete the protocol, which was
extensive and required a number of visits to the laboratory, were male. Consequently, future
studies are necessary to determine whether the effect of time of day on chemoreflex properties is
sex dependent.
The critical closing pressure is determined by both neuromuscular and nonneuromuscular properties. Non-neuromuscular properties and neuromuscular properties that
influence upper airway collapsibility may be separated if the airway is studied under conditions
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of hypo and hypertonia, respectively (McGinley et al., 2008a;Schwartz et al., 1998). However,
we chose not to perform our measures under separate conditions because we were concerned that
measures of the critical closing pressure under both conditions would not be possible in some
participants given the duration of our sleep sessions. Thus, to ensure that the upper airway
muscles were active, prior to completing brief step-downs in pressure, we maintained a holding
pressure that was 1-2 cmH2O below the therapeutic pressure. This reduction in pressure was
accompanied by a flow reduction of 10-15 %.

Thereafter, a negative pressure, relative to the

holding pressure, was rapidly applied. Based on published studies we speculate that each brief
step-down in pressure activated the negative pressure reflex within a short time period [i.e. 50 ms
(Horner et al., 1991;Horner et al., 1994)] resulting in a neuromuscular response that was affected
by the time of day. To support our contention we subsequently measured the critical closing
pressure using step-downs of longer duration, during which time neuromuscular responses were
undoubtedly influenced by the interaction between mechanoreceptors and chemoreceptors
(McGinley et al., 2008a). We surmised that if the critical closing pressure using the brief stepdowns in pressure was principally a reflection of non-neuromuscular influences on the upper
airway, contrary to our postulation, then the critical closing measurements would be more
positive compared to the critical closing pressure measurements attained using the prolonged
step-downs in pressure. This was not the case, since measures of the critical closing pressure
were similar and independent of the method used. Our findings suggest that the presentation of
additional stimuli which accompany prolonged step-downs in pressure might interact in a
complex fashion to produce a critical closing pressure similar to that induced by a brief negative
pressure pulse.

Alternatively, the similar measures could indicate a reduced upper airway

neuromuscular responsiveness to added stimuli that accompany prolonged step-downs in
pressure in individuals with sleep apnea.

This possibility has been reported previously
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(McGinley et al., 2008b).
Arousal state effects on breathing event characteristics
A secondary finding from our investigation was that the frequency and duration of
breathing events was greater during N2 compared to N1.

These results are contrary to

Ratnavadivel and colleagues (Ratnavadivel et al., 2009) findings, which showed that the
frequency of breathing events was reduced in N2 compared to N1. Ratnavadivel and colleagues
(Ratnavadivel et al., 2009) did not report the duration of breathing events and the corresponding
decrease in oxygen saturation. It is possible that breathing event duration increased accompanied
by greater reductions in oxygen saturation in N2 compared to N1, which is more in line with our
results. On the other hand, the discrepancy between our results and previous findings could be a
reflection of the quality of N2 sleep and the level of arousal following re-establishment of airway
patency.

Transitions from N1 to N2 sleep in individuals with sleep apnea are typically

characterized by continued promotion of apneic events, while the transition from N2 to N3 is
often linked to improved upper airway stability and decreases in event frequency (Eckert &
Younes, 2014a). Although direct comparisons of sleep depth in N2 between studies is not
possible, it is interesting to note that participants spent approximately 22 % of non-rapid eye
movement sleep in slow wave sleep in Ratnavadivel and colleagues investigation (Ratnavadivel
et al., 2009) while participants in our study spent little time in N3 (see Table 2).
Time of day effects on breathing event characteristics and upper airway collapsibility
Published findings have reported that the frequency and/or duration of breathing events
increases during the second compared to the first half of the night, independent of sleep stage
(Cala et al., 1996;Charbonneau et al., 1994;Fanfulla et al., 1997;Lavie et al., 1981;Montserrat et
al., 1996a;Sforza et al., 1998). We have extended these findings by showing that the increase in
the frequency and duration of breathing events during sleep in the morning are not only elevated
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compared to measures obtained during sleep in the evening, but also compared to sleep in the
afternoon. In previous studies, measures obtained during non-rapid eye movement sleep were
separated from rapid eye movement sleep to explore the time of day effect on event frequency
and duration independent of sleep stage (Cala et al., 1996;Charbonneau et al., 1994;Lavie et al.,
1981; Montserrat et al., 1996a;Sforza et al., 1998).

Although the potential confounding

influence of rapid eye movement sleep was controlled, the various stages of non-rapid eye
movement sleep were presumably combined in some investigations, since controls for non-rapid
eye movement sleep stage were undefined (Charbonneau et al., 1994;Fanfulla et al., 1997;Sforza
et al., 1998).

Consequently, increases in event frequency or duration during the second

compared to the initial half of the night could have been a reflection of alterations in the
contribution of N1, N2 and N3 to non-rapid eye movement sleep. Other studies limited analyses
to N2 of non-rapid eye movement sleep (Cala et al., 1996;Lavie et al., 1981;Montserrat et al.,
1996a). Thus, time of day effects on breathing event characteristics could potentially be specific
to N2 of non-rapid eye movement sleep. In the present investigation we explored if the effect of
time of day on frequency and duration of events differs between N1 and N2. Our results showed
that the frequency of events increased in the morning compared to the evening and afternoon in
N1 but not in N2. Alternatively, the duration of breathing events increased in the morning
compared to the evening and afternoon independent of the stage of non-rapid eye movement
sleep.
If all conditions, with the exception of event duration, remained constant for a given sleep
session one would anticipate that the decrease in oxygen saturation would be greater during
prolonged events. This was not the case, since the decrease in oxygen saturation was similar
across sleep sessions within N1 and N2. Consequently, a longer time interval was required to
attain a similar decrease in oxygen saturation. It is likely that the degree of oxygen desaturation
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was similar across sleep sessions because of differences in metabolic rate during sleep in the
morning compared to the afternoon and evening. Indeed, we recently reported that baseline
measures of minute ventilation, the partial pressure of end-tidal carbon dioxide and core body
temperature measured from 10 of the 13 participants in the present investigation, was
significantly less in the morning compared to the evening and afternoon (El-Chami et al.,
2014a). The addition of 3 participants did not alter this finding.
In support of the effect that time of day has on breathing event frequency and duration,
we also showed that the critical closing pressure that demarcates upper airway collapsibility was
greater in the morning compared to the evening and afternoon. Our study did not directly
address if an inherent modulation of tissue properties or upper airway neuromuscular function
was responsible for the increase in critical closing pressure in the morning. However, to our
knowledge, there is little evidence to suggest that time of day effects on tissue properties were
responsible for our results. On the other hand, there is substantial indirect evidence to suggest
that endogenous modulation of upper airway neuromuscular function could have contributed to
the effect of time of day on the critical closing pressure. Several studies have shown that skeletal
muscle torque, strength and power are higher in the late afternoon compared to the morning [see
(Zhang et al., 2009) for review]. These results have been obtained in a variety of muscles
ranging from the adductor pollicis (Martin et al., 1999) to leg extensor muscles (Sedliak et al.,
2008). Likewise, a decrease in the rate of tension development and one-half relaxation time has
been reported in the morning compared to the evening and afternoon (Martin et al., 1999).
Mechanisms responsible for the circadian modulation of upper airway collapsibility
There are multiple inputs and stimuli (Figure 9) presented on a nightly basis that could
potentially be responsible for increases in the critical closing pressure from the evening to the
morning, in individuals with sleep apnea.

However, in the present study the elimination of
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sleep apnea with continuous positive airway pressure, combined with the employed experimental
controls (i.e. maintenance of a supine position, similar sleep state), makes it unlikely that the
time of day effect on the critical closing pressure was a consequence of i) blunted feedback from
upper airway receptors in response to inflammation, edema and/or neural damage (Cala et al.,
1996) or ii) enhanced chemoreceptor feedback in response to intermittent hypoxia (Mateika &
Narwani, 2009;Mateika & Syed, 2013a;Mateika et al., 2015;Syed et al., 2013;Yokhana et al.,
2012). On the other hand, indirect evidence from animal studies indicate that endogenous
modulation of upper airway motor neurons could be responsible for the increase in the critical
closing pressure in the morning compared to the afternoon and evening. Serotonin, which is a
neuromodulator of hypoglossal motor neuron activity, varies in a diurnal pattern (Agren et al.,
1986;Mateos et al., 2009;Sun et al., 2002). Likewise, Volgin and colleagues (Volgin et al.,
2013) showed that the endogenous excitatory drive to hypoglossal motor neurons may be altered
through circadian mechanisms in part because of variations in the availability of 5-HT2A
receptors, which was quantified at the mRNA and protein level.
The manner in which serotonin ultimately modulates hypoglossal or other upper airway
motor neurons is unknown but one possibility could be linked to changes in metabolic rate, and
more specifically to the modulation of carbon dioxide. Synaptic connections from serotoninergic
neurons in the raphe pallidus and obscurus project to hypoglossal motor neurons (Manaker &
Tischler, 1993). These serotoninergic neurons sense carbon dioxide levels (Richerson, 2004),
which increase genioglossus muscle activity in healthy humans during wakefulness (Onal et al.,
1981;Patrick et al., 1982), and healthy humans (McSharry et al., 2013;Saboisky et al., 2010a) or
humans with obstructive sleep apnea (Loewen et al., 2011a) during non-rapid eye movement
sleep. Thus, fluctuations in carbon dioxide via the modulation of raphe neurons could ultimately
modulate upper airway muscle activity and collapsibility. Recently, we found that minute
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ventilation was reduced in the morning compared to the evening and afternoon coincident with
the nadir in core body temperature and PETCO2 (El-Chami et al., 2014a). Coincident reductions
in PETCO2 and temperature were also noted in the morning in the present investigation. More
importantly, decreases in the baseline partial pressures of carbon dioxide in the morning relative
to the afternoon and evening were correlated to increases in the critical closing pressure, in
support of the postulated role that carbon dioxide has in modulating upper airway collapsibility.
In addition to modulation of metabolic rate, circadian modulation of chemoreflex
properties (Figure 9) could also elicit fluctuations in carbon dioxide that promote increased upper

Figure 9. A schematic diagram showing a variety of inputs that impact on upper airway
collapsibility. Note that a number of stimuli (e.g. intermittent hypoxia, upper airway vibration
etc.) that progressively increase throughout the night as a consequence of sleep apnea activate a
variety of afferents that affect upper airway motor neuron and muscle activity. These inputs
could account for time of day effects on the duration and frequency of breathing events.
However, note that an endogenous circadian modulation of upper airway collapsibility, which
may be mediated by direct inputs to upper airway motor neurons and indirectly via adjustments
in chemoreflex sensitivity, occur despite the elimination of sleep apnea.
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airway collapsibility, and ultimately alterations in breathing event frequency and/or duration.
We recently discovered, using the experimental design employed in the present investigation,
that chemoreflex sensitivity and the carbon dioxide reserve (i.e. the difference between the
carbon dioxide that demarcates the point at which breathing is abolished and resting baseline
levels of carbon dioxide) increased and decreased, respectively, during sleep in the morning
compared to the evening and afternoon (El-Chami et al., 2014a). In the presence of cyclic
breathing events, increases in chemoreflex sensitivity and decreases in the carbon dioxide
reserve could elicit profound hypocapnia and disfacilitation of upper airway motoneurons,
increasing the propensity for upper airway collapse in the morning compared to the afternoon
and evening. Likewise, given that the response to hypoxia is blunted or absent in the presence of
hypocapnia (Rapanos & Duffin, 1997a;Wilson & Day, 2013a;Moore et al., 1984;Weil et al.,
1970a), it is possible that hypoxia does not significantly enhance receptor feedback prior to the
abolition of hypocapnia, despite enhanced chemoreflex sensitivity. This outcome, coupled with
the reduced metabolic rate in the morning, would delay the stimuli (i.e. hypoxia and
hypercapnia) required to activate the effective recruitment threshold of upper airway
motoneurons with the end result being an increase in breathing event duration.
Physiological significance
Increases in breathing event duration in the second half compared to the first half of the
night in individuals with sleep apnea has been attributed to progressive diminution of feedback
from upper airway sensory receptors in response to repeated trauma to pharyngeal tissues by
upper airway vibration and closure (Cala et al., 1996). In addition, it has been proposed that
progressive exposure to intermittent hypoxia and accompanying increases in chemoreflex
sensitivity could contribute to increased breathing instability in the latter half compared to the
initial half of the night. Thus, it has largely been accepted that consequences of sleep apnea (i.e.
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intermittent hypoxia, inflammation) are responsible for altering the complexion of breathing
events across the night (Deacon & Catcheside, 2014;Mahamed et al., 2003;Mateika, 2015). In
addition to these possibilities, our published findings (El-Chami et al., 2014a) and findings from
the present investigation have shown that an endogenous rhythm may contribute to modification
in breathing event characteristics. This effect may be mediated through a time of day effect on
chemoreflex properties (i.e. chemoreflex sensitivity and carbon dioxide reserve) in addition to an
inherent modulation of upper airway patency. Our findings lend credence to the possibility that
consequences of sleep apnea are likely to interact with endogenous modulation of mechanisms
that influence breathing instability.

Our results may have important implications for the

development of novel therapies to treat sleep apnea. More specifically, the effect of time of day
on the administered dose of therapies targeted toward mitigating diminution of upper airway
muscle function or increases in chemoreflex sensitivity and decreases in the carbon dioxide
reserve in the morning in patients with sleep apnea must be considered.
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CHAPTER 3 - THE EFFECT OF TIME OF DAY ON CHEMOREFLEX SENSITIVITY
AND THE CARBON DIOXIDE RESERVE DURING NREM SLEEP IN PARTICIPANTS
WITH SLEEP APNEA
(This chapter contains previously published material. See Appendix C)

Introduction
Clinical studies have reported that the number (Fanfulla et al., 1997; Salloum et al.,
2010) and duration of breathing events increase throughout the night (Charbonneau et al., 1994;
Fanfulla et al., 1997; Salloum et al., 2010) and that this increase is independent of sleep
architecture and body posture. Likewise, a reduction in apneic events during daytime compared
to nighttime sleep has been predicted by computer modeling simulations (Spengler et al. 2000),
and supported by experimental evidence which showed that the apnea-hypopnea index was
reduced during sleep in the day compared to the night in a small number of hypertensive men
(Robin et al, 1958).
The potential mechanisms underlying the increase in apnea severity are likely
multifactorial and phenotypically dependent (Dempsey et al., 2010;Orr et al., 2014;Younes,
2014). One possibility is that increases in chemoreflex sensitivity, coupled to a reduction in the
carbon dioxide reserve, are responsible for the progressive increase in breathing events across the
night (Mateika & Narwani, 2009;Mateika & Syed, 2013a).

This suggestion is supported

indirectly by Mahamed and colleagues, who reported that chemoreflex sensitivity to
hypercapnia/hyperoxia increased during wakefulness in the morning, following six hours of
sleep, compared to the evening in sleep apnea participants (Mahamed et al., 2005). Sforza and
colleagues also reported that respiratory drive, measured as the rate of increase in esophageal
pressure during apneic events, gradually increased throughout the night even though the degree
of oxygen desaturation and the rate of decrease in oxygen desaturation during apneic events were
constant (Sforza et al., 1998). These findings, along with the established understanding that
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enhanced chemoreflex sensitivity promotes the occurrence of both central and obstructive
breathing events provides support for the possibility that alterations in chemoreflex properties
contribute to the promotion of breathing events at different points throughout the sleep period
(Dempsey et al., 2004;Dempsey, 2005;Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika
& Syed, 2013a;Yokhana et al., 2012).
There are at least two possible mechanisms responsible for reported increases in
chemoreflex sensitivity.

The first is that exposure to intermittent hypoxia during sleep is

responsible for the reported increase in chemoreflex sensitivity during wakefulness in the
morning compared to the evening in patients with sleep apnea (Mateika & Narwani,
2009;Mateika & Syed, 2013a). This hypothesis is supported by our work and others which have
shown that exposure to intermittent hypoxia during wakefulness enhances chemoreflex
sensitivity in healthy individuals (Griffin et al., 2012;Mateika et al., 2004a;Morelli et al.,
2004;Wadhwa et al., 2008) and individuals with sleep apnea (Gerst, III et al., 2011;Khodadadeh
et al., 2006). The second possibility is that alterations in chemoreflex properties reflect an
endogenous oscillation that is linked to time of day. Indeed Spengler et al. (Spengler et al., 2000)
and Stephenson et al. (Stephenson et al., 2000) have reported that chemoreflex sensitivity during
wakefulness in healthy participants is modulated by a circadian rhythm. Despite these findings,
no studies have examined in individuals with sleep apnea if chemoreflex properties (i.e. apneic
threshold, carbon dioxide reserve and chemoreflex sensitivity) are modulated during sleep
according to the time of day and independent of intermittent hypoxia. The present investigation
was designed to fill this void. Based on the published literature we hypothesized that
chemoreflex sensitivity would be greater and the carbon dioxide reserve reduced in the morning
compared to measures obtained during sleep in the afternoon and evening.
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Methods
Protocol
The Human Investigation Committees of Wayne State University School of Medicine
and John D. Dingell Veterans Affairs Medical Center approved the experimental protocol. Ten
male participants with pure or predominantly obstructive (i.e., a central component combined
with an obstructive component) sleep apnea but no other comorbidities (e.g., heart and lung
disease, hypertension, and obesity) completed the protocol. Participants that completed the
protocol visited the laboratory on 6 occasions. During the first visit to the laboratory, written
informed consent was obtained and thereafter a physical examination, health and lifestyle
questionnaires, blood pressure and lung volume measures along with a 12-lead EKG were
completed. After ensuring that inclusion criteria were met, participants completed a baseline
nocturnal polysomnogram to confirm the presence of obstructive sleep apnea (visit 2). Upon
verification, participants were enrolled into the protocol and given an actigraph watch
(Actiwatch Spectrum, Philips Respironics Inc., Murraysville, PA). The watch was used to
monitor the sleep-wake schedule of the participants while they slept at home for two weeks prior
to obtaining physiological measurements on visits 4-6 (see subsequent paragraph for further
details). We requested that the participants adhere to a regular sleep-wake schedule with a sleep
onset time between 10-11 pm and a wake time of 7-8 am. We also requested that the participants
avoid daytime napping. During the two week period the participants returned to the laboratory
for a third visit. During this visit continuous positive airway pressure was administered during
sleep to determine the positive pressure required to maintain airway patency. In addition, a
“practice trial” using the methodology and procedures required to determine the apneic
threshold, chemoreflex sensitivity and the carbon dioxide reserve was completed so that each
participant experienced the required data collection methods and procedures prior to obtaining
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formal measurements.
After the two week time period participants returned to the laboratory on three separate
occasions (i.e. visits 4-6). Each of these visits was separated by a minimum of 7 days. We
requested that the participants maintain a regular sleep-wake schedule during the 7 day interval
that separated each visit. Details regarding two of the visits along with the corresponding results
will be presented in separate publications. During one of these visits core body temperature was
measured for a minimum of 27 hours. One of the final three visits was designed to measure the
apneic threshold, chemoreflex sensitivity and carbon dioxide reserve at three time points during
the day/night cycle. Two days prior to these visits participants were asked to abstain from
alcohol and caffeinated beverages. On the day of the study participants arrived at the laboratory
at approximately 7:30 pm.

Upon arrival the participants ingested a radiotelemetry pellet

(CorTemp® Sensor, HQInc, Palmetto, FL) in order to measure core body temperature every 10 s
throughout the visit. This measure was used to establish the nadir of core body temperature and
to confirm that this low point was similar to that measured during the study completed over a
minimum time period of 27 hours. Following instrumentation, participants slept for three hours
during 3 separate sleep sessions (i.e. 10 pm - 1 am, 6 - 9 am, and 2 - 5 pm). Subsequent to each
sleep session participants were placed in a semi-recumbent position during wakefulness. At the
onset of each wake session (i.e. 1- 6 am and 9 am -2 pm) participants watched a movie for 120
minutes and immediately thereafter read for 90 minutes. Ninety minutes prior to the morning or
afternoon sleep session the participants sat quietly and did not engage in any activity. During
each wake session participants received small snacks every 95 minutes composed of
approximately 15 % fat, 75 % carbohydrate and 10 % protein. Moreover, participants received
up to a maximum of 1 liter of water over the length of the constant routine protocol. During
wakefulness the participants were in a dimly lit laboratory that was separated from sunlight and
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external cues including phones, clocks, radios and television. The laboratory temperature was
controlled at 22-23°C.
Interventions and procedures
During each sleep session, nasal noninvasive positive pressure mechanical ventilation
was used to induce hyperventilation to determine the hypocapnic ventilatory response and the
apneic threshold (Figure 3A).

Mechanical ventilation was applied for 3 minutes in a

spontaneous-timed pressure support mode, as described in previous publications (Mateika et al.,
2004b;Salloum et al., 2010). In this mode, a backup respiratory rate of 6–8 breaths/min was
preset and timed breaths delivered if the participant‘s respiratory rate fell below the set rate. The
ventilator respiratory rate, which was below the participant’s eupneic rate, was set to prevent
neuromechanical inhibition of ventilatory motor output. During mechanical ventilation, the
inspiratory positive airway pressure was increased gradually in 1 to 2 cmH2O increments at the
beginning of each mechanical ventilation trial, while the expiratory positive airway pressure was
fixed throughout mechanical ventilation at a pressure that eliminated apnea but maintained a
reduction in airflow of 15 - 20 % in each participant to prevent over distension of the airway.
Mechanical ventilation was terminated after 3 minutes, during expiration, by returning the
inspiratory positive airway pressure to the baseline expiratory positive airway pressure. The
ensuing hypocapnia resulted in either a hypopnea or central apnea (Figure 10A). If an apnea was
not induced, additional hyperventilation trials were completed until an apnea was evident or
arousal from sleep prevented the completion of additional trials. Central apnea was defined as an
expiratory time ≥ 5 s. Each hyperventilation trial was separated by a five minute period of
baseline breathing.
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Figure 10. An illustration of the data collection and analysis procedures used to elicit a hypocapnic
induced apnea. (A) A single trial which shows that after measuring baseline ventilation and the
partial pressure of carbon dioxide (PETCO2), mechanical hyperventilation reduced carbon dioxide
levels below baseline. Once mechanical ventilation ceased an apnea was evident during recovery.
(B) A scatterplot obtained from one participant illustrating the minute ventilation response to stepwise reductions in PETCO2. In this example, reductions in PETCO2 occurred over 9 separate trials
(open circles) until an apnea was achieved. The difference between baseline PETCO2 and the PETCO2
that demarcated the apneic threshold was considered to be the carbon dioxide reserve. The slope of
the regression line fit to the data points was considered to be the chemoreflex sensitivity.

Instrumentation
During sleep studies the monitoring montage included an electroencephalogram (C3/A2,
C4/A1,

O1/A2,

electrocardiogram.

O2/A1),

electrooculograms,

submental

electromyogram

and

an

Chest wall and abdominal movements were measured using inductive

plethysmography (Respitrace, Ambulatory monitoring, Inc., Ardsley, NY). Airflow and breath
timing (inspiratory and expiratory time) were measured using a pneumotachometer (Model
RSS100-HR, Hans Rudolph Inc., Shawnee, KS) attached to a nasal mask. Oxygen saturation
(SaO2) was measured with a pulse oximeter (Biox 3700; Ohmeda, Boulder, CO). Measures of
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end–tidal oxygen (Model 17515, Vacumed, Ventura, CA) and end–tidal carbon dioxide (Model
17518, Vacumed Inc., Ventura, CA) were obtained from air expired into sampling tubes attached
to ports on the face mask. Nasal pressure was measured using a pressure transducer attached via
tubing to a port on the nasal mask. Upper airway pressure was measured using a transducer
tipped catheter (Mikro-Cath 825-0101, Millar, Inc., Houston, TX) to confirm apnea and ascertain
the presence of flow limitation. All physiological variables were analogue to digitally converted
at a sampling frequency of 100 Hz/channel and input into a computer using a commercially
available software package (Gamma Version 4.0, Astro-Med Inc., West Warwick, RI). The
cardio-respiratory variables were also input into a second computer using a commercially
available software package (WinDaq, Dataq Instruments Inc., Akron, OH).
Data analysis
All polysomnography studies were analyzed for sleep stage, arousals, and respiratoryrelated events according to standard published criteria. The hyperventilation trials completed
during the evening, morning and afternoon sleep sessions were analyzed if associated with N2 or
N3 of non-rapid eye movement sleep with an absence of arousal or ascent to N1. For each trial
within a given session, the baseline period was represented by breaths recorded during the two
minutes that immediately preceded the onset of mechanical ventilation. An average of the
baseline periods measured during a given sleep session was calculated. The average of the last
five mechanically ventilated breaths before the ventilator was returned to a baseline expiratory
positive airway pressure were averaged to represent the tidal volume achieved during the
hyperventilation period. The change in PETCO2 was calculated as the difference between the
PETCO2 recorded during the control period and the PETCO2 associated with the last five
mechanically ventilated breaths. Minute ventilation was given a value of 0 once a central apnea
was induced.
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The apneic threshold was defined by the PETCO2 associated with the occurrence of an
apnea (Figure 10B). The carbon dioxide reserve was defined as the difference in PETCO2
measured during baseline breathing and the PETCO2 that demarcated the occurrence of an apnea
(Figure 10B).

Chemoreflex sensitivity was determined by dividing the change in minute

ventilation (i.e. the difference between minute ventilation measured during baseline and minute
ventilation measured once the ventilator was returned to an expiratory positive airway pressure)
and the change in PETCO2 (i.e. the difference between PETCO2 measured during baseline and the
PETCO2 that demarcated an apnea) (Figure 10B).
Measurements of core body temperature were purified to eliminate small fluctuations in
temperature associated with movements during wakefulness that occurred during feeding or
bathroom breaks.

Thereafter, the temperature was fit with a cosine wave (y = m + acos

(2πt/ω+ϕ); where y is the temperature, m is the circadian rhythm adjusted mean (i.e. mesor), a is
the amplitude of the circadian rhythm, t is time (hours), ω is the period of the circadian rhythm, ϕ
is the phase angle. Once the phase and period of the core body temperature was established for
an individual, this information was used to assign a circadian phase (from 0 to 359°) to each
minute, with 0° corresponding to the minimum of the waveform fitted to the core body
temperature data. The plotted data was then used to determine the session that corresponded to
the core body temperature nadir.
Statistical analysis
A one-way repeated measures analysis of variance in conjunction with Student-Newman
Keuls post hoc test was used to compare baseline levels of PETCO2 and minute ventilation, the
PETCO2 that demarcated the apneic threshold, chemoreflex sensitivity and the carbon dioxide
reserve measured during the evening, morning and afternoon sleep sessions. Data are presented
as means along with individual data points to signify variability.

A p value ≤ 0.05 was
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considered statistically significant.
Results
Table 3 shows the anthropometric variables obtained for the group. The results show that
the participants were young, and not obese as indicated by the body mass index.

The

apnea/hypopnea index ranged from mild to severe according to standard criteria. However, the
level of oxygen desaturation achieved during apneic/hypopneic events was mild even in those
participants considered to have severe sleep apnea.

Systolic and diastolic blood pressure

measurements were within normal limits and the Epworth sleepiness scale indicated a history of
mild sleepiness while scores from the Stanford sleepiness scale indicated normal alertness for
both groups on the day of the screening visit (Table 3). The average therapeutic pressure
required to eliminate apnea during sleep on visit 2 in the OSA participants was 11.2 ± 0.7
cmH2O.
Table 3. Baseline anthropometric, blood pressure and sleep measures
Variable
Age, yr.
Height, cm
Weight, kg
Body mass index, kg/m2
Systolic pressure, mmHg
Diastolic pressure, mmHg
Epworth Sleepiness Scale
Apnea/hypopnea index, events/hr
Lowest oxygen desaturation during apnea, %
Race

29.8 ± 2.1
172.5 ± 5.0
80.7 ± 3.2
26.2 ± 0.7
121.7 ± 2.0
74.2 ± 2.9
10.3 ± 1.3
39.1 ± 5.1
87.5 ± 1.1
6 AA, 2 Caucasian, 1 Asian, 1 Indian

The nadir of core body temperature was evident during the morning session (Figure 11).
Baseline measures of minute ventilation were lower in the morning compared to values in the
evening (p < 0.02) and afternoon (p < 0.02) (Figure 12A). A corresponding decrease in tidal
volume (Figure 12B), but not breathing frequency (Figure 12C), was evident in the morning
compared to the evening (p < 0.04) and afternoon (p < 0.04). Baseline PETCO2 was reduced in
the morning (p < 0.002) and afternoon (p < 0.02) compared to the evening (Figure 13); while the
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PETCO2 values that demarcated the apneic threshold were similar across the evening, morning
and afternoon sessions (Figure 13). The carbon dioxide reserve was reduced in the morning (2.1
± 0.25 mmHg) compared to the evening (3.6 ± 0.5 mmHg) (p < 0.002) and afternoon (3.5 ± 0.3
mmHg) (p < 0.001) (Figure 13), while chemoreflex sensitivity was increased in the morning
compared to the evening (p < 0.001) and afternoon (p < 0.001) (Figure 12D).

Figure 11. Average values of core body temperature of 10 participants with sleep apnea shown
in 30 minute increments over a 24 hour cycle. Note that the nadir in temperature occurred at 6
am and the peak at 7:30 pm (vertical arrows). Zero time represents the onset of the temperature
recording (9:00 p.m.).
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Figure 12. Combined histograms and scatterplots which show the group mean, and mean values
for each participant, calculated from measures of (A) baseline minute ventilation (B) baseline
tidal volume (C) baseline breathing frequency and (D) the hypocapnic ventilatory response,
during the evening, morning and afternoon sleep sessions. Note that minute ventilation along
with tidal volume was reduced and the hypocapnic ventilatory response increased in the
morning compared to the afternoon and evening. † significantly different compared to the
evening and afternoon.

47

Figure 13. Combined histograms and scatterplots which show the group mean, and mean values
for each participant, calculated from baseline measures of the partial pressure of carbon dioxide
(PETCO2) (group average indicated by top of the gray bars and individual data indicated by the
black circles), the PETCO2 that demarcates the apneic threshold (group average indicated by
bottom of the gray bars and individual data indicated by white circles) and the carbon dioxide
reserve indicated by the vertical dashed line parallel to each histogram bar. Note that baseline
PETCO2 was reduced in the morning and afternoon compared to the evening (*) and that the
carbon dioxide reserve was reduced in the morning compared to the evening and afternoon (†).

Discussion
We employed a constant routine protocol to measure chemoreflex properties during nonrapid eye movement sleep across the 24-hour cycle in participants with sleep apnea. Our
primary findings were that the carbon dioxide reserve was reduced and chemoreflex sensitivity
was increased during sleep in the morning compared to the evening and afternoon.
Baseline measures of ventilation PETCO2, temperature and time of day
Previous studies have employed constant routine protocols to directly measure ventilation
over a 24 hour period of wakefulness in healthy humans breathing room air (Adamczyk et al.,
2008;Spengler et al., 2000;Vargas et al., 2001), or breathing air comprised of elevated levels of
carbon dioxide (Stephenson et al., 2000) or reduced levels of oxygen (Vargas et al., 2001).
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Collectively, a circadian oscillation in minute ventilation (Adamczyk et al., 2008;Spengler et al.,
2000;Stephenson et al., 2000), or it components tidal volume and breathing frequency
(Adamczyk et al., 2008), has been reported; although the circadian rhythm of minute ventilation
approached but did not reach statistical significance in one investigation (Spengler et al., 2000).
The nadir of minute ventilation occurred in the early morning in the majority of studies
(Adamczyk et al., 2008;Stephenson et al., 2000), but in one case was evident in the early
evening (Spengler et al., 2000). Our results are similar to published findings since a significant
reduction in minute ventilation and tidal volume was evident in the morning compared to the
evening and afternoon.
Mortola suggested that circadian variations in minute ventilation in humans are mediated
almost exclusively by changes in arousal state under the normal light dark routine accompanied
by fluctuations in sleep and wakefulness (Mortola, 2004). However, our results, coupled with
previous findings (Adamczyk et al., 2008;Spengler et al., 2000;Stephenson et al., 2000), indicate
that the observed fluctuations in minute ventilation are in part influenced by the time of day,
since fluctuations are evident under constant routine conditions when wakefulness and sleep are
controlled. Although the fluctuation in minute ventilation is small, it is robust, since it remained
evident despite variability in the constant routine protocols employed in published studies
(Adamczyk et al., 2008;Spengler et al., 2000;Stephenson et al., 2000) and the present
investigation (e.g. 24 hours of sleep deprivation vs. 3 hour sleep sessions interspersed with
wakefulness). Thus, our results, coupled with previous findings, have established that minute
ventilation varies according to the time of day during both non-rapid eye movement sleep and
wakefulness in humans.
In addition to examining the effect of time of day on minute ventilation, simultaneous
measures of core body temperature and PETCO2 over a 24 hour period of wakefulness, while
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breathing room air, has also been measured in a few studies (Spengler et al., 2000;Stephenson et
al., 2000;Vargas et al., 2001). In these studies a well-established oscillation in core body
temperature (Hofstra & de Weerd, 2008) was evident with the nadir occurring during the early
morning hours (i.e. 6 - 8 am) (Spengler et al., 2000;Stephenson et al., 2000;Vargas et al., 2001).
However, the relationship between minute ventilation and core body temperature varied, with
core body temperature in phase with minute ventilation in one investigation (Stephenson et al.,
2000) but lagging 6-8 hours in another (Spengler et al., 2000).
An obvious but small oscillation (~ 1-2 mmHg) in PETCO2 has also been documented
(MILLS, 1953;Spengler & Shea, 2000;Vargas et al., 2001), and the relationship between minute
ventilation and PETCO2 was reportedly in phase (i.e. decreases in ventilation were accompanied
by decreases in PETCO2) with the nadir of the measures occurring between 6 pm and midnight
(Spengler & Shea, 2000). In agreement with previous findings we showed in the present
investigation that the nadir of core body temperature occurred in the early morning hours.
Moreover, minute ventilation and PETCO2 were significantly lower during sleep in the morning
compared to the evening and afternoon. Given that we were not able to obtain continuous
measures during sleep over the period of our investigation we cannot state definitely that minute
ventilation and PETCO2 were in phase with the nadir of core body temperature. However, given
our results it is unlikely that the nadir of core body temperature lagged minute ventilation and
PETCO2 to the degree reported in a previous investigation (Spengler & Shea, 2000).
It has long been established that PETCO2 is influenced by arousal state, increasing during
sleep compared to wakefulness (Mortola & Maskrey, 2011;ROBIN et al., 1958). However, our
results, along with previous findings (MILLS, 1953;Spengler et al., 2000;Vargas et al., 2001),
confirm that within a sleep or wake state PETCO2 is effected by the time of day. Moreover, our
results reveal that a coincident reduction in minute ventilation and PETCO2 occurred in
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conjunction with core body temperature. The mechanism responsible for the coincidental nadir
in minute ventilation and PETCO2 during the morning or the increase in minute ventilation and
PETCO2 in the other sessions is unknown.

However, given the increase in chemoreflex

sensitivity (see Chemoreflex properties and time of day for further discussion) that we measured
in the morning, compared to the afternoon and evening, it seems unlikely that chemoreflex inputs
were principally responsible for the coincidental decrease in ventilation and PETCO2 observed in
our investigation. This finding is intriguing, since it is generally accepted that minute ventilation
during non-rapid eye movement sleep is controlled solely by input from the chemoreflexes in
healthy humans (Phillipson EA & Bowes G, 1986).

Alternatively, given the coincident

variations in core body temperature, minute ventilation and PETCO2 in the present investigation,
coupled with similar published findings that included measures of metabolic rate during
wakefulness (Spengler et al., 2000), indicates a robust link between minute ventilation and
metabolism. Despite this result the mechanism responsible for the link between metabolism and
minute ventilation remains unknown. Perhaps parallel inputs to the respiratory controller and
temperature regulation network is responsible for the coincident reduction in minute ventilation,
PETCO2 and temperature that was observed. Indeed, activation of the nucleus tractus solitarius
and ventrolateral medulla in rats induces a coincident decrease in temperature and PETCO2 (Cao
et al., 2010).
Chemoreflex properties and time of day
A number of studies have examined the effect of time of day on chemoreflex properties
in healthy humans during wakefulness (Fuse et al., 1999;Mahamed et al., 2005;Raschke &
Moller, 1989;Siekierka et al., 2007;Spengler et al., 2000;Stephenson et al., 2000). Some studies
were designed to measure the threshold and/or chemoreflex sensitivity in the evening, prior to
sleep, and in the morning, immediately after sleep (Fuse et al., 1999;Mahamed et al., 2005). The
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results were variable in that the ventilatory response to increases in carbon dioxide during
wakefulness were reported to be unchanged (Fuse et al., 1999) or altered as a consequence of a
decrease in the chemoreflex threshold (Mahamed et al., 2005) in the morning compared to the
evening. Differences in the methodology used to measure chemoreflex properties, and the
composition of populations recruited for each study could account for some of the variability
(Fuse et al., 1999;Mahamed et al., 2005). Nonetheless, despite this variability the reported
change (Mahamed et al., 2005) or lack thereof (Fuse et al., 1999) would tend to promote the
maintenance of breathing stability across the evening to morning transition.
Other studies have measured chemoreflex properties in healthy humans over a 24 hour
period (Raschke & Moller, 1989;Siekierka et al., 2007;Spengler et al., 2000;Stephenson et al.,
2000). In two studies the participants were awake and inactive throughout the constant routine
protocol (Spengler et al., 2000;Stephenson et al., 2000). In the remaining studies measurements
were also made during wakefulness (Raschke & Moller, 1989;Siekierka et al., 2007); however
participants were either allowed to sleep at will (Raschke & Moller, 1989), or sleep for 2 hours
from 4-6 a.m. in addition to engaging in moderate physical activity (Siekierka et al., 2007).
Results from these studies revealed that a circadian oscillation in the ventilatory response to
isocapnic hypoxia (Raschke & Moller, 1989;Siekierka et al., 2007) or the ventilatory response to
carbon dioxide in the presence of normoxia (Raschke & Moller, 1989;Spengler et al., 2000) or
hypoxia (Stephenson et al., 2000) was evident. The acrophase of the ventilatory response to
isocapnic hypoxia reportedly occurred at noon and remained relatively constant at other times
throughout the 24 hour cycle (Siekierka et al., 2007). Inclusion of exercise and one period of
sleep in the constant routine protocol may have influenced the results (Siekierka et al., 2007).
Spengler and Shea reported that the acrophase of the ventilatory response to carbon dioxide (i.e.
as a result of an increase in chemoreflex sensitivity) was evident between the hours of 10 a.m.
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and 2 p.m., while the bathyphase which was evident starting at 6 pm remained stable for 12-14
hours (Spengler et al., 2000). In other studies the acrophase of the ventilatory response to carbon
dioxide, either as a consequence of an increase in the chemoreflex threshold (Stephenson et al.,
2000) or a decrease in chemoreflex sensitivity (Raschke & Moller, 1989), was evident later in
the evening (6 p.m.) while the onset of the bathyphase was manifested in the morning (Raschke
& Moller, 1989;Stephenson et al., 2000). Although some discrepancies exist between studies,
collectively the results suggest that the ventilatory response to hypoxia or carbon dioxide may
remain relatively stable or decrease across the hours normally associated with sleep in healthy
humans.
To our knowledge only two studies have explored the effect of time of day on
chemoreflex properties in participants with sleep apnea (Fuse et al., 1999;Mahamed et al., 2005).
In both studies measures of the chemoreflex threshold (Mahamed et al., 2005) and/or
chemoreflex sensitivity (Fuse et al., 1999;Mahamed et al., 2005) were obtained during
wakefulness in the evening, prior to sleep, and in the morning, immediately after sleep (Fuse et
al., 1999;Mahamed et al., 2005).

Mahamed and colleagues reported that the chemoreflex

sensitivity to hyperoxia/hypercapnia was increased in the morning compared to the evening
(Mahamed et al., 2005), while Fuse reported that no changes in chemoreflex sensitivity were
evident (Fuse et al., 1999). Mahamed and colleagues (Mahamed et al., 2005) suggested that the
reasons for the discrepant findings was that Fuse et al. (Fuse et al., 1999) used a standard
hyperoxic rebreathing technique that measures ventilatory responses in the hypercapnic range of
50–80 mmHg, whereas Mahamed at al. used a modified rebreathing technique that measures
ventilation in the normocapnic range of 35–60 mmHg (Mahamed et al., 2005). Independent of
this difference, the design of both studies eliminated the possibility of examining the effect of
time of day on chemoreflex properties in humans with obstructive sleep apnea during sleep.
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More specifically, measures were not obtained during sleep so that measures of chemoreflex
properties during wakefulness in the morning were likely impacted by stimuli linked to breathing
events (e.g. arousal, intermittent hypoxia) that occurred during the preceding sleep period (Fuse
et al., 1999;Mahamed et al., 2005). Our primary findings filled this void and revealed that the
ventilatory response to hypocapnia was significantly enhanced, while the carbon dioxide reserve
was reduced, in the morning compared to the evening and afternoon. Conversely, the PETCO2
that demarcated the apneic threshold remained stable across the 3 sleep sessions. Given this
stability, the reduction in the carbon dioxide reserve in the morning was due principally to a
reduction in baseline carbon dioxide. Thus, a fundamental alteration in chemoreflex properties
linked solely to the time of day might exist in sleep apnea participants compared to healthy
humans, if our analysis of the published results from healthy humans is correct (see preceding
paragraph for further discussion).
Physiological significance
A few clinical studies have reported that the number (Fanfulla et al., 1997;Sforza et al.,
1998) and duration (Cala et al., 1996;Charbonneau et al., 1994;Sforza et al., 1998) of breathing
events increase throughout the night independent of sleep architecture and body posture.
Likewise, a reduction in apneic events during daytime compared to nighttime sleep has been
predicted by computer modeling simulations (Stephenson, 2004), and supported by experimental
evidence which showed that the apnea-hypopnea index was reduced during sleep in the day
compared to the night in a small number of hypertensive men (Scharf et al., 1990).
The duration of breathing events might be increased as a consequence of diminished
feedback from upper airway sensory receptors which Cala and colleagues have suggested is due
to repeated trauma to pharyngeal tissues as a consequence of upper airway vibration and closure
(Cala et al., 1996). Alternatively, an increase in breathing instability and the number of events
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from the beginning to the end of the night may be driven by an increase in chemoreflex
sensitivity and a reduction in the carbon dioxide reserve, respectively (Mateika & Narwani,
2009;Mateika & Syed, 2013a). Indeed our findings support this suggestion, since chemoreflex
sensitivity was increased and the carbon dioxide reserved decreased in the morning compared to
the afternoon and evening.
One of the stimuli which could initiate increases in chemoreflex sensitivity is intermittent
hypoxia, a hallmark of sleep apnea (Mateika & Narwani, 2009;Mateika & Syed, 2013a). Indeed
numerous studies reported that exposure to intermittent hypoxia during wakefulness increases
the ventilatory response to carbon dioxide and sustained hypoxia (Gerst, III et al.,
2011;Khodadadeh et al., 2006;Mateika et al., 2004a;Morelli et al., 2004;Wadhwa et al., 2008).
However, questions remained regarding whether or not chemoreflex properties were altered over
time during sleep in participants with sleep apnea. Our results have partially filled this void,
since we established that chemoreflex sensitivity is increased and the carbon dioxide reserved is
decreased in the morning compared to the afternoon and evening. We also ascertained that these
alterations were linked to the time of day independent of exposure to intermittent hypoxia. Thus,
progressive increases in chemoreflex sensitivity during sleep in participants with sleep apnea
could in part be the cause and not the consequence of breathing events. Our findings may have
important implications for the development of novel therapies to treat sleep apnea.

More

specifically, the effect of time of day on the administered dose of pharmaceuticals agents
targeted toward mitigating the impact that increases in chemoreflex sensitivity and/or decreases
in the carbon dioxide reserve have on breathing instability in patients with sleep apnea should be
considered (Wang et al., 2013).
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CHAPTER 4 - IMPACT OF AROUSAL THRESHOLD AND CHEMOREFLEX
SENSITIVITY ON APNEA FREQUENCY AND DURATION IN PARTICIPANTS WITH
SLEEP APNEA
Introduction
We reported that the frequency and duration of apneic events is dependent on sleep stage
(El-Chami et al., 2015). More specifically, we showed that the duration and frequency of events
was greater in N2 compared to N1 sleep, independent of the time of day (El-Chami et al., 2015).
The observed increase in event duration in N2 could be caused by an increase in the arousal
threshold, along with an increase in the effective recruitment threshold for upper airway muscle
activity (Cala et al., 1996;Eckert & Younes, 2014b;Montserrat et al., 1996b). Alternatively, a
blunted respiratory response to afferent inputs (e.g. chemoreflex and mechanoreceptor inputs),
reflected by a decrease in the rate of change of respiratory effort during apneic events in N2
could be responsible for sleep stage related differences in apneic duration. The relationship
between event duration and arousal threshold or respiratory response sensitivity should impact
on respiratory effort immediately prior to termination of an event, and closely after establishment
of airway patency.
Kimoff and colleagues reported that the rate of change of respiratory effort during
breathing events in N2 is independent of event duration (Cala et al., 1996;Montserrat et al.,
1996b). Thus, respiratory effort at the termination of an event might reflect increases in the
arousal or effective recruitment threshold. If these findings are consistent across sleep states the
rate of change of respiratory effort during events in N1 compared to N2 may be similar.
However, the maximum response at the termination of an event and immediately upon reestablishment of upper airway patency may be increased if the arousal threshold or effective
recruitment threshold is increased in N2 compared to N1.
completed in part to test this hypothesis.

The present investigation was
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In addition to the variation in event duration and frequency in N2 compared to N1, we
also recently reported that event duration was greater in the morning compared to the afternoon
and evening within a given sleep stage (i.e. N2) (El-Chami et al., 2015), consistent with previous
published findings (Cala et al., 1996;Charbonneau et al., 1994;Fanfulla et al., 1997;Lavie et al.,
1981;Montserrat et al., 1996a;Sforza et al., 1998). Likewise, event frequency was greater in the
morning during N1 (El-Chami et al., 2015). We provided evidence which suggested that the
effect of time of day on the duration and frequency of breathing within a given stage of sleep
might be mediated by a circadian variation in both chemoreflex sensitivity (El-Chami et al.,
2014b), and upper airway collapsibility (El-Chami et al., 2015). Explicitly, we found that an
increase in chemoreflex sensitivity coupled to a decrease in the carbon dioxide reserve, and a
more collapsible airway, was evident in the morning during N2 compared to the afternoon and
evening (El-Chami et al., 2014b). These findings were evident despite the absence of hallmarks
of sleep apnea (i.e. intermittent hypoxia) (El-Chami et al., 2014b).
The variation in chemoreflex properties could result in an increased rate of change in
respiratory effort during an event in a given stage based on the time of day. This postulation is
supported by the findings of Sforza et al. (Sforza et al., 1998) but is in contrast to the findings of
Kimoff and colleagues who reported that the rate of change of respiratory effort modified by
pressure changes that activate upper airway mechanoreceptors, or increases in central respiratory
drive, was not altered by the time of day (Cala et al., 1996;Montserrat et al., 1996b). Likewise,
variations in chemoreflex properties, coupled to a more collapsible airway and consequently an
increased effective recruitment threshold, could result in an upsurge in respiratory effort
immediately at the termination of an event and following re-establishment of airway patency (ElChami et al., 2015). The increase in effort following re-establishment of airway patency could
lead to hypocapnia and the initiation of subsequent events upon re-establishing the sleep state
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(Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika & Syed, 2013b). This postulation is
supported indirectly by Kimoff and colleagues (Cala et al., 1996;Montserrat et al., 1996b) who
showed that the respiratory effort immediately prior to termination of the event was greater in the
morning compared to the evening. To test the hypotheses stated above respiratory effort during
events, immediately prior to termination of events, and closely after establishing airway patency
was measured during N1 and N2 of non-rapid eye movement sleep in the evening and morning
in individuals with obstructive sleep apnea.
Methods
Protocol
Findings discussed in this chapter resulted from the same visits we conducted to measure
the frequency and duration of breathing events at different times of the day. For a detailed
description of the protocol and instrumentation, refer to the protocol section of Chapter 2.
Data analysis
All polysomnography studies were analyzed for sleep stage, arousals, and respiratoryrelated events in accordance with standard published criteria. An apnea was identified as an
event in which there was a cessation of inspiratory airflow for a minimum of 10 s. An event
accompanied by a > 50% reduction in airflow that lasted for a minimum of 10 s and was
accompanied by either an arousal, or a ≥ 3% reduction in oxygen saturation in the absence of an
arousal, was classified as a hypopnea. The duration and number of apneas and hypopneas, along
with the decrease in oxygen saturation that occurred during each event, was established for N1
and N2 of non-rapid eye movement sleep for each sleep session completed during Visit 4. The
rate of change of upper airway inspiratory pressure from the start to the end of each breathing
event (∆ pressure ÷ ∆ time) detected during N1 and N2 sleep was determined (Figure 14).
Analyses of events recorded in N3 were excluded from the results because the total amount of
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Figure 14. A raw figure showing the various parameters analyzed during an apneic event
appearing in non-rapid eye movement sleep. Note that upper airway pressure was measured at
the beginning and immediately prior to the termination of an event (see upper airway pressure
– B and E). In addition, the difference between these measures (see upper airway pressure –
delta) divided by the duration of the event was used to determine the rate of change of the
respiratory effort during an event. Lastly, note that immediately following the termination of
an event the maximum tidal volume and the lowest partial pressure of end-tidal carbon dioxide
(PETCO2) within the initial 3 breaths after event termination was recorded.
time spent in N3 was insufficient to make comparisons between participants or sleep sessions.
The lowest airway inspiratory pressure associated with the last respiratory attempt prior to
termination of each event was also ascertained (Figure 14). Lastly, the tidal volume response of
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the greatest magnitude, coupled with the accompanying fractional concentration of end-tidal
carbon dioxide, was recorded from 1 of the initial 3 breaths after termination of a breathing event
(Figure 14).
The decrease in carbon dioxide associated with the breath of the greatest magnitude
following a breathing event was subtracted from baseline measurements of the partial pressure of
end-tidal carbon dioxide measured from a 2-min period of stable non-rapid-eye-movement sleep
during the evening and morning sleep sessions completed during visit 5 or 6 (El-Chami et al.,
2015;El-Chami et al., 2014b). Baseline measures were obtained from these visits because a
patent airway was established with continuous positive airway pressure in contrast to visit 4 in
which a stable baseline period was not available to obtain baseline measures of the fractional
concentration of carbon dioxide.
Statistical analysis
A two-way repeated measures ANOVA in conjunction with Fisher’s least square
difference post hoc test was used to compare the rate of change of respiratory effort, maximum
effort immediately prior to event termination as well as the tidal volume and partial pressure of
end-tidal carbon dioxide immediately after establishing airway patency. The two factors in the
analysis were sleep stage (i.e. N1 and N2) and time of day (i.e. evening and morning). A paired
t-test was used to compare the difference in the partial pressure of end-tidal carbon dioxide
induced by hyperventilation and carbon dioxide measures that demarcated the apneic threshold
obtained during N2 in the evening and morning. The end-tidal carbon dioxide measures were
standardized to baseline measures.
Results
Table 4 shows the anthropometric variables obtained for the group. The participants
were young to middle age, and not obese, as indicated by the body mass index.

The
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apnea/hypopnea index determined from the screening sleep study (i.e. Visit 2) ranged from mild
to severe according to standard criteria. The level of oxygen desaturation achieved during
apneic/hypopneic events was mild even in those participants considered to have severe sleep
apnea. Systolic and diastolic blood pressure measurements were within normal limits and the
Epworth sleepiness scale indicated a history of mild sleepiness (Table 4). The nadir of core body
temperature was evident in the early morning during visit 4. Participants spent 73.4 ± 4.9 % and
78.0 ± 2.7 % of the total session time (i.e. 3 hours) in non-rapid eye movement sleep in the
evening and morning (P ≥ 0.47) during visit 4. The percentage of time spent in N1 or N2 for a
given 3-hour sleep session was not significantly different between the evening and morning (P ≥
0.85).
Table 4: Baseline anthropometric, blood pressure and sleep measures
Variable
Age, yr.
Height, cm
Weight, kg
Body mass index, kg/m2
Systolic pressure, mmHg
Diastolic pressure, mmHg
Epworth Sleepiness Scale
Apnea/hypopnea index, events/hr
Lowest oxygen desaturation during apnea, %
Race

29.6 ± 2.3
177.1 ± 2.1
83.8 ± 2.6
26.6 ± 0.7
118.7 ± 3.1
70.9 ± 3.0
10.0 ± 1.2
44.4 ± 5.2
86.5 ± 1.3
6 AA, 3 Caucasian, 1 Asian, 1 Indian

Values are means ± SE

Respiratory effort was measured from an average of 48.8 ± 10.2 events during N1 and
from 178.1 ± 25.2 events during N2 in each participant. The rate of change of respiratory effort
during N1 compared to N2 was not significantly different (P = 0.83) (Figure 15A). Conversely,
the upper airway inspiratory pressure associated with the last respiratory attempt prior to event
termination was greater during N2 compared to N1 (P  0.04) (Figure 15B). This increase was
accompanied by a greater decrease in oxygen saturation in N2 compared to N1 (P  0.002)
(Figure 15C). Likewise, following event termination tidal volume was greater (P  0.03) (Figure
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15D) and the partial pressure of end-tidal carbon dioxide was less (P  0.05) (Figure 15E) in N2

Figure 15. Histograms (mean ± S.E.) showing the rate of change in epiglottic pressure (A),
epiglottic pressure at the termination of an event (B), change in oxygen saturation during events
(C), maximum tidal volume immediately following an event (D), lowest partial pressure of endtidal carbon dioxide (PETCO2) immediately following an event (E) and duration of breathing
events (F) during N1 (white histograms) and N2 (gray histograms) of non-rapid eye movement
sleep. ‡ significantly different from N1; * significantly different from the evening.
compared to N1. Respiratory effort during events and the magnitude of tidal volume after event
termination was unrelated to the degree of flow limitation during hypopneic events which was
similar in N1 compared to N2 (48.1 ± 2.2 vs. 47.4 ± 2.4 % of baseline, P = 0.34). Likewise, the
number of events associated with an arousal at event termination (expressed as a percentage of
the total number of events) was similar in N1 compared to N2 (77.3 ± 4.4 vs. 82.9 ± 4.0 % of
events, P = 0.18). Thus, the presence or absence of an arousal at the termination of an event
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likely did not account for differences in post event measures of tidal volume. The increase in
respiratory effort during and following events in N2 were coupled to an increase in event
duration during N2 compared to N1 (P  0.004) (Figure 15F).
The rate of change of respiratory effort was similar in the evening compared to the
morning (P = 0.34) (Figure 15A), as was the upper airway inspiratory pressure measured for the
last respiratory event prior to event termination (P = 0.88) (Figure 15B) and the decrease in
oxygen saturation (P = 0.13) (Figure 15C). In contrast, following event termination, tidal
volume was greater (P  0.01) (Figure 15D) and consequently the partial pressure of end-tidal
carbon dioxide was less (P  0.05) (Figure 15E) in the morning compared to the evening
independent of sleep stage. The decrease in the partial pressure of carbon dioxide in response to
hyperventilation in the morning was below the apneic threshold compared to the partial pressure
of end-tidal carbon dioxide which remained slightly above the apneic threshold in the evening (P
 0.02) (Figure 16). The duration of events was greater in the morning compared to the evening
independent of sleep stage (P  0.001) (Figure 15F).
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Figure 16. Histograms which show
the group mean values calculated
from baseline measures of the partial
pressure of end-tidal carbon dioxide
(PETCO2), the PETCO2 that demarcates
the apneic threshold (AT) which was
previously published and the lowest
PETCO2
measured
immediately
following breathing events in the
present investigation (dashed line;
PH–post hyperventilation). Note that
in the morning the PETCO2 initiated
by post hyperventilation was below
the apneic threshold in contrast to the
evening. † PETCO2 initiated by PH
standardized to the AT significantly
different in the morning compared to
the evening.
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Discussion
We discovered that the rate of change of respiratory effort during breathing events was
similar throughout N2 and N1, even though the duration of events was greater in N2 compared to
N1. Coupled to the increase in duration the respiratory effort immediately prior to and after
termination of an event was greater in N2 compared to N1. The increase in respiratory effort
(i.e. tidal volume) after termination of an event was coupled to a reduced partial pressure of endtidal carbon dioxide. We also found that within a given stage of non-rapid eye movement sleep
(i.e. N1 or N2) the rate of change of respiratory effort and the maximum respiratory effort
immediately prior to termination of an event was similar in the morning compared to the
evening, whereas the duration of breathing events was greater in the morning. Despite the
similarity in respiratory effort during events, tidal volume was greater and the partial pressure of
end-tidal carbon dioxide was reduced once airway patency was re-established in the morning
compared to the evening.
Mechanisms responsible for the increase in event frequency & duration in N2 compared to N1
In our previous investigation we found that the duration of breathing events was
increased during N2 compared to N1 of non-rapid eye movement sleep.

At least two

mechanisms could be responsible for the increase as outlined above (see Introduction). The
increase could be caused by a rise in the arousal threshold along with an increase in the effective
recruitment threshold for upper airway muscle activity. Alternatively, a blunted respiratory
response to afferent inputs (e.g. chemoreflex and mechanoreceptor inputs) reflected by a
decrease in the rate of change of respiratory effort during apneic events in N2 could be
responsible for sleep stage related difference in apnea duration. Kimoff and colleagues reported
that the rate of change of respiratory effort during breathing events in N2 is independent of event
duration (Cala et al., 1996;Montserrat et al., 1996b). If this finding is consistent across sleep
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states then a similar rate of change of respiratory effort during events in N2 compared to N1
would be expected. This expectation was confirmed by our results which showed that the rate of
change of respiratory effort was similar in N2 compared to N1. In contrast, we showed that the
respiratory effort immediately prior to termination of events in N2 was greater compared to N1.
Thus, our results imply that increases in the arousal threshold and effective recruitment threshold
had a role in the prolongation of event duration during N2 compared to N1.
Our results also showed that the magnitude of the tidal volume response was greater and
the partial pressure of end-tidal carbon dioxide was reduced immediately following termination
of breathing events in N2 compared to N1. The increase in the tidal volume response was
independent of the degree of flow limitation and the number of events accompanied by arousal.
Thus, we propose that an elevated arousal threshold leading to an increase in event duration
during N2 was accompanied by enhancement of respiratory stimuli that contributed to the
augmented tidal volume response evident following termination of events in N2.

This

suggestion is supported by our results which showed a greater decrease in oxygen saturation
during events in N2.

Consequently, termination of an event was likely accompanied by

increased chemoreceptor input (Pillar et al., 2000;Loewen et al., 2011b;Nicholas et al.,
2010;Saboisky et al., 2010b;Stanchina et al., 2002), along with other sensory inputs (Berry et al.,
1995;Cala et al., 1996;McNicholas et al., 1987), that initiated increases in tidal volume coupled
with reductions in the partial pressure of end-tidal carbon dioxide that exceeded measures
following events in N1. Independent of the mechanisms responsible for the increased end-apnea
ventilatory response the accompanying hypocapnia could increase the likelihood of perpetuating
apneic events in N2 compared to N1 (Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika
& Syed, 2013b). This suggestion is supported by our previous findings which showed that the
frequency of breathing events was increased in the evening and afternoon in N2 compared to N1
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of non-rapid eye movement sleep (El-Chami et al., 2015). The presence of hypocapnia at the
onset of subsequent events may have also contributed to prolonging event duration; since
additional time would be required to reach a level of carbon dioxide that was sufficient to
terminate events in N2 compared to N1.
Mechanisms responsible for the increase in event frequency and duration in the morning
compared to the evening
We previously reported that the frequency of events increased in the morning compared
to the evening and afternoon in N1 (El-Chami et al., 2015). This difference was also evident in a
subgroup of participants (n = 5) during N2 (El-Chami et al., 2015). As shown in the present
investigation (see Figure 15) and in our previously published work (El-Chami et al., 2015) the
duration of breathing events increased in the morning compared to the evening independent of
the stage of non-rapid eye movement sleep.
The increase in event duration in the morning compared to the evening in both N1 and
N2 suggest that the arousal threshold along with the effective recruitment threshold of the upper
airway muscles following airway collapse was higher in the morning compared to the evening.
This suggestion is supported by previous results which showed that the respiratory effort
immediately prior to termination of an event in N2 was increased in the morning compared to the
evening, while the rate of change in respiratory effort during breathing events was not altered by
the time of day (Cala et al., 1996;Montserrat et al., 1996b). We also found that the rate of
change of respiratory effort was similar during events within N1 and N2 in the evening and
morning. However, in contrast to previously published findings (Cala et al., 1996;Montserrat et
al., 1996b) we found that the maximum respiratory effort at the termination of events was similar
in the evening and morning within N1 and N2. Thus, alterations in the arousal threshold or the
sensitivity of the respiratory response to afferent inputs during events may not provide the sole
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explanation for increases in event duration in the morning compared to the evening. We propose
that modulation of the carbon dioxide reserve, coupled to differences in metabolic rate linked to
the time of day contribute to the prolongation of event duration in the morning.
Earlier we showed that an increase in chemoreflex sensitivity coupled to a reduction in
the carbon dioxide reserve was evident in the morning compared to the evening (El-Chami et al.,
2014b). The increase in chemoreflex sensitivity likely contributed to the increase in tidal volume
and the decrease in the partial pressure of end-tidal carbon dioxide that was evident in the
morning compared to the evening within N1 or N2 in the present investigation. Moreover, the
increase in chemoreflex sensitivity coupled to a decrease in the carbon dioxide reserve in the
morning likely ensured that the level of hypocapnia relative to the apneic threshold was greater
at the onset of an event in the morning compared to evening. Indeed, measures of end-tidal
carbon dioxide immediately following event termination in the present investigation, coupled to
previously published measures of the apneic threshold (El-Chami et al., 2014b), showed that the
partial pressure of carbon dioxide in response to hyperventilation in the morning dropped below
the apneic threshold but remained above it in the evening. Given that studies have shown that
the response to hypoxia is blunted or absent in the presence of hypocapnia (Rapanos & Duffin,
1997b;Weil et al., 1970b;Wilson & Day, 2013b), it is possible that hypoxia does not significantly
enhance receptor feedback prior to the abolition of hypocapnia, despite enhanced chemoreflex
sensitivity. In addition, activation of chemoreflex inputs was likely reduced by a decrease in
metabolic rate in the morning. We have shown that core body temperature, minute ventilation
and end tidal carbon dioxide are reduced in the morning compared to the evening (El-Chami et
al., 2014b). In addition, in the present study decreases in oxygen saturation were similar in the
morning compared to the evening even though event duration was longer in the morning
compared to the evening. Thus, the presence of hypocapnia at the onset of events coupled with
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the reduced metabolic rate in the morning could delay the stimuli (i.e. hypoxia and hypercapnia)
required to activate the arousal and effective recruitment threshold, resulting in an increased
event duration. Likewise, the increased probability of carbon dioxide levels being less than
values that demarcate the apneic threshold would likely contribute to increasing the frequency of
apneic events (Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika & Syed, 2013b).
Conclusion
We conclude that alterations in the arousal threshold, reflected by an increase in
respiratory effort at event termination, coupled to increases in tidal volume and reductions in
PETCO2 contribute to modifications in event duration and frequency associated with variations in
sleep state or time of night.
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CHAPTER 5 - MILD INTERMITTENT HYPOXIA WITH SUSTAINED
HYPERCAPNIA REDUCES THERAPEUTIC CPAP AND IMPROVES AIRFLOW IN
PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA
Introduction
Long-term facilitation is characterized by a sustained increase in respiratory motor
activity following exposure to mild intermittent hypoxia (Mateika and Syed, 2013). A sustained
increase in motor activity has been recorded at sites within the medulla and spinal cord that
control ventilation and at sites in the medulla responsible for the control of upper airway muscles
(Mateika and Fregosi, 1997; Babcock and Badr, 1998; Trumbower et al. 2012). Long-term
facilitation of phrenic motor nerve activity and ventilation has been initiated in a variety of
species including healthy humans, humans with sleep apnea and spinal cord injured humans
(Aboubakr et al., 2001; Fuller et al., 2003, Wadhwa et al., 2008; Devinney et al. ,2013; Tester et
al. 2014). Likewise, long-term facilitation of the hypoglossal nerve or the genioglossus muscle
has been observed in a number of animals including humans (Fuller et al., 2001; Fuller, 2005;
Chowdhuri et al., 2008; McKay et al., 2004). Given that long-term facilitation of upper airway
muscle activity can be initiated by intermittent hypoxia we and others hypothesized that the
initiation of this phenomenon might improve upper airway patency in humans with sleep apnea
(Mateika and Fregosi, 1997; Babcock and Badr, 1998; Aboubakr et al., 2001). This led to the
possibility that apnea severity across the night might improve as a consequence of natural
exposure to intermittent hypoxia. However, a number of studies have revealed that apnea
severity increases rather than decreases from evening to morning (Fanfulla et al. 1997; Cala et
al, .1996; Sforza et al., 1998). We have addressed the potential reasons for the lack of influence
of long-term facilitation on apnea severity in previous reviews (Mateika and Syed, 2013 ;
Mateika et al., 2015 ; Mateika and Komnenov, 2016). Briefly there are a variety of mechanisms
(i.e. chemoreflex sensitivity, carbon dioxide reserve, airway inflammation) that are modulated
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across the night that likely prevent or predominate over the influence potentially exerted by longterm facilitation of upper airway muscle activity on airway collapsibility. Consequently, we
postulated that if these detrimental influences were minimized or eliminated then the effects of
long-term facilitation might manifest more clearly. More specifically we reasoned that improved
upper airway patency via the initiation of long-term facilitation could potentially serve to reduce
the positive airway pressure required to treat individuals with sleep apnea. This reduced pressure
could improve treatment compliance, which is reportedly limited (Sawyer et al., 2011), and
ultimately the co-morbidities (i.e. cardiovascular, metabolic and neurocognitive) linked to sleep
apnea.

This possibility coupled to the direct effects of intermittent hypoxia on these co-

morbidities that have been reported could serve as novel adjunct therapy to treat sleep apnea and
its multiple co-morbidities. Thus, the present investigation was designed primarily to determine
if long-term facilitation of upper airway muscle activity initiated by exposure to intermittent
hypoxia serves to reduce the therapeutic positive airway pressure required to maintain airway
patency in individuals with obstructive sleep apnea.
Long-term facilitation is mediated by at least two cellular pathways deemed the Q and S
pathway (DeVinney et al., 2013). It is has been hypothesized that the Q pathway is initiated by
mild intermittent hypoxia. This pathway is regulated in part by serotonin in addition to other
neuromodulators. Serotonin along with the proteins and kinases that have been identified within
the Q pathway are reportedly modulated by a circadian rhythm (Agren et al., 1986, Mateos et al.,
2009, Sun et al., 2002, Serchov and Heumann, 2006). If so, then the magnitude of long-term
facilitation would be expected to vary according to the time of day. Indeed we previously
reported that the magnitude of long-term facilitation of ventilation in humans was greater in the
evening compared to the morning (Gerst et al., 2011).

Thus, a secondary aim of this

investigation was designed to determine if the impact of long-term facilitation on the therapeutic
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positive pressure required to treat obstructive sleep apnea was modulated by the time of day.
Methods
Protocol
The Human Investigation Committees of Wayne State University School of Medicine
and John D. Dingell Veterans Affairs Medical Center approved the experimental protocol. Ten
male participants completed the protocol by visiting the laboratory on six different occasions
(Figure 17).

On the first visit, informed consent was obtained from participants before

completion of a physical examination and health and lifestyle questionnaires. In addition, blood
pressure, lung volumes and a 12-lead ECG were obtained to confirm the absence of
comorbidities (i.e. heart and lung disease, hypertension, and obesity). During the second visit,
participants completed a diagnostic nocturnal polysomnogram to determine the presence of
obstructive sleep apnea. Once confirmed participants maintained a regular sleep cycle at home
for a two week period to ensure a consistent circadian rhythm. Sleep/wake times were monitored
via an actigraph watch (Actiwatch Spectrum, Philips Respironics, Murraysville, PA). During
this two week period, participants returned to the laboratory for an overnight visit (i.e. visit 3) to
acclimate to continuous positive airway pressure ventilation and to determine the therapeutic
pressure required to eliminate breathing events.

Figure 17. A schematic diagram showing the protocol completed by the participants. * Sham
protocol was conducted in the evening and morning only. † Administration of IH was
randomized to evening or morning
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After the two week period, participants returned for a 4th visit to complete a 21-hour
constant routine protocol (Figure 17).

Participants arrived at the laboratory at 8 pm and

completed 3 separate sleep sessions from 10 pm to 1 am, 6 am to 9 am and 2 pm to 5 pm.
During each session the therapeutic continuous positive pressure airway pressure was
established. Thereafter a sham protocol, emulating the timeline of the intermittent hypoxia
intervention applied in visits 5 and 6 (see below for further for details), was completed. During
this time interval the partial pressure of end-tidal oxygen and carbon dioxide remained unaltered.
Following completion of the protocol the continuous positive airway pressure was reduced in 1-2
cmH2O decrements to compare measures of respiratory parameters (see Data Analysis for details
of respiratory parameters) at similar pressures following exposure to intermittent hypoxia and
sustained hypercapnia.
During the 5 hours between sessions, participants were awake and in a semi-recumbent
position. The room was dimly lit with a luminance of 30 lux, while the temperature and
humidity were maintained between 22-24° C and 25-35%, respectively.

The participants

watched a movie (i.e. non-stimulating light comedies or documentaries) for two hours, followed
by 90 minutes of reading, and 30 to 45 minutes of inactivity prior to the start of the setup for the
following sleep session. The subjects received small snacks with a constant caloric content
every 95 minutes (composition: 75 % carbohydrates, 15% protein and 10% fat) and a maximum
of 1L of water. During completion of the protocol participants were isolated from external cues
such as sunlight, TV, clocks, phones, computers, radios, and internet.
During visits 5 and 6 the therapeutic pressure for a given sleep session was established
and baseline (i.e. B1) measures of respiratory parameters (see Data Analysis for respiratory
parameters measured) were obtained over a minimum of 10 minutes (Figure 18). The partial
pressure of end-tidal carbon dioxide (PETCO2) was then increased by 3 mmHg and measures of
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Figure 18. Diagram showing the severity and pattern of intermittent hypoxia. The tracings
illustrates the changes in the partial pressure of end-tidal oxygen (PETO2) (upper) and carbon
dioxide (PETCO2) (middle) and the alterations in continuous positive airway pressure throughout
the protocol (bottom)
the respiratory parameters were obtained for an additional 10 minutes during the second baseline
(B2) period (Figure 18). Thereafter, participants inspired a gas mixture comprised of 8 % oxygen
and balance nitrogen to achieve a partial pressure of end-tidal oxygen (PETO2) (~ 55 mmHg) that
resulted in an oxygen saturation of 88 % (Figure 20). Maintenance of the PETO2 was achieved by
the addition of 100 % oxygen into the circuit using a flowmeter. Participants were exposed to
this gas mixture 12 times for two-minutes each time. The 12 hypoxic episodes were separated
by 2 minute recovery intervals with the exception of the recovery period that followed the 12th
hypoxic episode, which was 15 minutes in duration. For presentation purposes the 15 minute
recovery period was divided into three 5 minute segments. Throughout the protocol, including
the end recovery period, the PETCO2 was maintained at 3 mmHg above baseline (Figure 18).
After the 15 minute end-recovery period the continuous positive airway pressure was reduced in
1-2 cmH2O steps. The participants were exposed to the IH and sustained hypercapnia during an
evening (10 pm to 1 am) and morning session (6 am to 9 am) on separate occasions (Visits 5 and
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6), which were randomized.

When the participants were exposed to IH and sustained

hypercapnia in the morning they were treated with continuous positive airway during the evening
session without exposure to the hypoxic stimulus.
Instrumentation
During the sleep studies the monitoring montage included an electroencephalogram
(C3/A2, C4/A1, O1/A2, O2/A1), electrooculograms, submental electromyogram, and an
electrocardiogram.

Chest wall and abdominal movements were measured using inductive

plethysmography (Respitrace, Ambulatory Monitoring, Ardsley, NY).

Airflow and breath

timing (inspiratory and expiratory time) were measured using a pneumotachometer (model
RSS100-HR, Hans Rudolph, Shawnee, KS) attached to a nasal mask. Oxygen saturation (arterial
O2 saturation) was measured with a pulse oximeter (Biox 3700; Ohmeda, Boulder, CO).
Measures of end-tidal oxygen (Model 17515, Vacumed, Ventura, CA) and carbon dioxide
(Model 17518, Vacumed, Ventura, CA) were obtained from air expired into sampling tubes
attached to ports on the nasal mask. Nasal pressure was measured using a pressure transducer
attached via tubing to a port on the nasal mask. Upper airway pressure was measured using a
transducer tipped catheter (Mikro-Cath 825-0101, Millar, Houston, TX) to confirm apnea and
ascertain the presence of flow limitation. All physiological variables were analog to digitally
converted at a sampling frequency of 100 Hz/channel and input into a computer using a
commercially available software package (gamma version 4.0, Astro-Med, West Warwick, RI).
The cardiorespiratory variables were also input into a second computer using a commercially
available software package (WinDaq, Dataq Instruments, Akron, OH).
Data analysis
Nocturnal polysomnography. All polysomnography studies were analyzed in 30s epochs
for sleep stage and arousals. In addition, during the second visit respiratory-related events were
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scored according to standard published criteria.

Apneas were defined as the cessation of

inspiratory flow for 10 seconds or more, while hypopneas were characterized by a decrease in
inspiratory flow of more than 50% accompanied by a 3% (or greater) blood oxygen desaturation
and/or an arousal from sleep. The apnea hypopnea index (i.e. the average number of respiratory
events per hour) was determined to ensure that the severity of sleep apnea fell within the
inclusion criteria.
Intermittent hypoxia protocol. The physiological parameters measured throughout the
protocol were ventilation, PETCO2, PETO2, SaO2, heart rate, tidal volume and breathing
frequency. Average absolute values of the parameters were obtained from the last 2 minutes of
B1, B2, the last minute of each hypoxic and recovery period and the last two minutes of each
decrement in continuous positive airway pressure. Select data were standardized to B2 to
compare results between the intermittent hypoxia and sham protocol.

This analysis was

completed because measures of minute ventilation and tidal volume were greater during B2 of
the intermittent hypoxia compared to the sham protocol because PETCO2 was increased 3 mmHg
above baseline during B2 of the intermittent hypoxia protocol. Average values of tidal volume,
airflow and upper airway resistance were determined from 10 breaths measured during the last
minute of B2. Data from the last minute of end recovery and from two step downs were
standardized to B2 measures. The selected step downs in pressure were equivalent to values of
positive pressure that resulted in a 25 % and 50 % reduction in airflow during the sham protocol.
Resistance was defined as the inverse of the average slope of the linear portion in the
pressure/flow loop (Figure 19). In order to obtain the slope, commercial software (Matlab) was
used to calculate the slope of a series of 3 sequential data points measured during inspiration
prior to a plateau in airflow (Figure 19). The slopes were then averaged for each breath.
Thereafter a 10 breath average was calculated for each selected period outlined above.
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Figure 19. Figure showing the method used to measure upper airway resistance. A tangent line
was fit to 3 consecutive points throughout the inspiratory portion of the breath prior to maximal
flow to determine resistance (1/slope of the tangent line).
Sham protocol. The sham protocol was completed to compare the changes (or lack
thereof) in the physiological parameters following exposure to the continuous positive airway
pressure for a duration comparable to the one required to complete the intermittent hypoxia
protocol. The comparison serves to ensure that the hypothesized improvement in upper airway
and breathing stability were due to intermittent hypoxia and sustained hypercapnia. Analysis of
the data measured during the sham protocols was identical to the analysis completed for the
intermittent hypoxia trials (see explanation above).
Statistical analysis
A two way analysis of variance with repeated measures in conjunction with Student
Newman Keuls post hoc test was used to compare data measured during B2 of the intermittent
and sham protocol. The factors in the design were “protocol” (intermittent hypoxia vs. sham)
and “time of day” (evening vs. morning). A similar analysis was used to compare the data
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within a given protocol (i.e. intermittent hypoxia or sham). The factors in the design were “time
point” (B2 vs. End Recovery 1, 2 & 3 vs. Step Down 1, 2, 3 & 4) and “time of day” (evening vs.
morning). Lastly, this analysis was used to compare the standardized data across the intermittent
hypoxia and sham protocols. The factors in the design were “time point” (B2 vs. End Recovery
vs. Step Down 25 % & 50 %) and “time of day” (evening vs. morning). Data are presented as
means ± SE. P ≤ 0.05 was considered statistically significant. 0.05 < P ≤ 0.07 was considered to
be characteristic of a trend toward significance.
Results
Table 5 shows the anthropometric variables obtained for the group. Collectively, the
participants were young to middle age, and not obese, as indicated by the body mass index. The
apnea/hypopnea index determined from the screening sleep study (i.e., Visit 2) ranged from mild
to severe according to standard criteria. The level of oxygen desaturation achieved during
apneic/hypopneic events was mild even in those participants considered to have severe sleep
apnea. Systolic and diastolic blood pressure measurements were within normal limits and the
Epworth sleepiness scale indicated a history of mild sleepiness.

The average therapeutic

pressure required to eliminate apnea during sleep on visit 3 in the obstructive sleep apnea
participants was 11 ± 0.7 cmH2O.
Table 5. Baseline anthropometric, blood pressure and sleep measures
Variable
Age, yr.
Height, cm
Weight, kg
Body mass index, kg/m2
Systolic pressure, mmHg
Diastolic pressure, mmHg
Epworth Sleepiness Scale
Apnea/hypopnea index, events/hr
Lowest oxygen desaturation during apnea, %
Race
Values are means ± SE

25.2 ± 2.2
178.3 ± 5.5
83.6 ± 3.1
25.7 ± 0.9
120.1 ± 3.2
72.2 ± 3.3
8.3 ± 1.4
37.03 ± 5.2
88.8 ± 1.4
7 Caucasian ,2 AA , 1 Indian
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The therapeutic pressure required to eliminate apnea during B2 of the sham protocol in
the evening and the morning was 11.2 ± 0.6 and 12.4 ± 0.5 cmH2O, respectively.

The

therapeutic pressure required to eliminate apnea during B2 of the intermittent hypoxia protocol in
the evening and the morning was 12.1 ± 0.7 and 13.1 ± 0.7 cmH2O, respectively.

The

therapeutic pressure required to eliminate apnea was significantly less in the evening compared
to the morning during the intermittent hypoxia and sham protocol (P < 0.02). The therapeutic
pressure during B2 of the intermittent hypoxia protocol tended to be increased compared to the
therapeutic pressure measured at the same time point during the sham protocols in the evening
and morning (P < 0.06).
Measures of the physiological parameters obtained during B1 and B2 of the sham and
intermittent hypoxia protocols are shown in Figure 20. Note that by design PETCO2 during B2
was greater during the intermittent hypoxia compared to the sham protocols (P < 0.005).
Consequently, minute ventilation (P < 0.001) and tidal volume (P < 0.001) were greater during
B2 of the intermittent hypoxia compared to the sham protocols.
Following exposure to intermittent hypoxia minute ventilation (P < 0.001) and tidal
volume (P < 0.001) during end-recovery and the step-downs in positive pressure were greater
compared to B2 (P < 0.001) (Figure 20). Consequently, PETO2 was greater during the endrecovery period following exposure to intermittent hypoxia compared to B2 (P < 0.01) (Figure
20). The increases observed following exposure to intermittent hypoxia were evident even
though the therapeutic pressure (P = 0.4) and PETCO2 (P = 0.3) during the end-recovery periods
were similar to measures obtained during B2. The increase in minute ventilation tended to be
greater (P = 0.07) and the increase in tidal volume was greater (P = 0.04) in the evening
compared to the morning (Figure 20).

Following exposure to the sham protocol minute

ventilation (P > 0.7) and tidal volume (P > 0.3) during end–recovery and the step-downs in
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positive pressure were similar to B2.

Figure 20. Scatter plots showing changes in end-tidal PETCO2, PETO2, minute ventilation, tidal
volume, blood oxygen saturation (SaO2), breathing frequency, and continuous positive airway
pressure throughout the intermittent hypoxia and sham protocols. *significantly different than
baseline ; ‡significantly different than the evening.
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As expected the increase in tidal volume observed during the end recovery period was
coupled to an increase in inspiratory flow following exposure to intermittent hypoxia (P < 0.003)
but not after the sham protocol (Figure 21). Likewise, airway resistance during the end recovery
period was significantly reduced following exposure to intermittent hypoxia compared to the
sham protocols (P < 0.03). The increase in inspiratory flow and the decrease in resistance
following exposure to intermittent hypoxia during the end recovery period were similar in the
evening and the morning. Inspiratory flow and resistance remained at baseline levels following
exposure to intermittent hypoxia after the therapeutic positive airway pressure was reduced by 5
cm H2O (Figure 21). In contrast, after completion of the sham protocol inspiratory flow was
reduced (P < 0.001) and resistance was increased (P < 0.01) in response to the 5 cm H2O
reduction in positive airway pressure (Figure 21).

After the positive airway pressure was

reduced by 7 cm H2O following exposure to intermittent hypoxia, inspiratory flow was reduced
and resistance was greater compared to baseline in some participants but not others.
Consequently, these measures were not significantly different from baseline.

In contrast,

inspiratory flow was reduced and resistance were greater than baseline following the sham
protocol (P < 0.04) (Figure 21). The changes in inspiratory flow after the 5 and 7 cm H2O
reduction in positive airway pressure during recovery from the intermittent hypoxia and sham
protocols were similar in the evening and morning (Figure 21). In contrast, resistance measures
were greater in the morning compared to the evening after the positive airway pressure was
reduced by 5 and 7 cm H2O following the sham protocol (see 5 and 7 cm H2O) (P < 0.02)
(Figure 21).
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Baseline resistance values in cmH2O/L/s

Figure 21. Histograms showing airflow (top) and upper airway resistance (bottom) after
completion of the intermittent hypoxia or sham protocols. Measures were obtained at baseline
therapeutic pressure and following decreases in pressure that corresponded to a 25 and 50%
decrease in airflow during the sham protocol. Note that despite the decrease in pressure, flow and
resistance were not significantly altered compared to baseline and the sham protocols.
*significantly different than baseline; †significantly different than sham; ‡significantly different
than the evening.
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Discussion
We confirmed our previous findings that exposure to mild intermittent hypoxia initiates
long-term facilitation of minute ventilation during sleep in individuals treated with continuous
positive airway pressure. Novel findings from our investigation indicated that exposure to mild
intermittent hypoxia initiates long-term facilitation of upper airway muscle activity.

The

initiation of this phenomenon was reflected by an increase in airflow and a reduction in airway
resistance during treatment with positive airway pressure following exposure to intermittent
hypoxia. Moreover, airflow and airway resistance were maintained at baseline levels even after
positive airway pressure was reduced below therapeutic values. In addition to our primary
findings, our secondary findings revealed that upper airway patency could be modulated by a
circadian rhythm, which supports our previous findings.

More specifically the therapeutic

pressure required to maintain airway patency was higher in the morning compared to the evening
during completion of the sham protocols. Likewise, a reduction in positive airway pressure
below therapeutic values (i.e. 7 cm H2O) resulted in an increase in airway resistance which was
greater in magnitude in the morning compared to the evening.
Critique of experimental protocol
In the present investigation mild intermittent hypoxia was used to initiate respiratory
plasticity. The use of intermittent hypoxia as a therapeutic modality is counterintuitive to the
findings from a number of animal studies which suggested that intermittent hypoxia causes
autonomic, metabolic and neurocognitive dysfunction (Fletcher 1995, 1997, 2000 and 2001).
However, to our knowledge there is little to no evidence that mild intermittent hypoxia leads to
these detrimental outcomes which have been linked to long-term exposure to severe levels of
hypoxia. Instead, a number of reviews, with the support of published research findings, have
convincingly outlined that numerous beneficial outcomes might be linked to exposure to mild

82
intermittent hypoxia (Mateika et al.,2015; Mateika and Komnenov, 2016; Serebrovskaya et al.,
2008).

However, we did report previously that some forms of respiratory plasticity (i.e.

progressive augmentation) initiated by acute exposure to mild intermittent hypoxia promotes
breathing instability particularly when other forms of plasticity that could be beneficial (i.e. longterm facilitation) are neutralized (Yokhana et al., 2012).

Therefore we proposed that the

potential beneficial effects of long-term facilitation might only manifest if the detrimental forms
of plasticity are eliminated or mitigated. Thus we proposed that the beneficial effects of longterm facilitation will be clearly evident once the influence of progressive augmentation was
mitigated or eliminated with continuous positive airway pressure.
In our investigation intermittent hypoxia was combined with a level of carbon dioxide
that was sustained slightly above baseline levels. The maintenance of carbon dioxide throughout
the intermittent hypoxia protocol was employed to ensure that long-term facilitation of
ventilation clearly manifested itself throughout the protocol; since we previously established that
long-term facilitation typically does not manifest in the presence of hypocapnia (Mateika and
Sandhu, 2011). Given the employment of carbon dioxide levels that were above baseline it
could be argued that the long-term facilitation that was evident, and coupled to reduced upper
airway resistance and collapsibility, was induced principally by forms of respiratory induced by
increased levels of carbon dioxide. However, we previously completed control experiments
which showed that the magnitude of long-term facilitation of ventilation was determined wholly
or principally by exposure to intermittent hypoxia and not sustained hypercapnia (Harris et al.,
2006). Moreover, we showed that repeated daily exposure to elevated levels of carbon dioxide
did not lead to long-term facilitation of minute ventilation. In contrast, repeated daily exposure
to intermittent hypoxia led to a progressive increase in the magnitude of long-term facilitation.
It has been standard practice to measure airway resistance as the inverse of the slope at a
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specific point on the linear portion of the flow-pressure curve. However, given the complex
dynamic nature of the airway during inspiration the customary method neglects the progression
of airway mechanics and thus measures only reflect the initial portion of inspiration. Therefore
airway resistance at points closer to termination of inspiration is not reflected in the
measurement. The method we used reflects the average resistance measured throughout the
inspiratory phase prior to a plateau in inspiratory flow. It is reasonable to suggest that the
method we employed does not control for the potential impact of a number of variables that
might influence airway resistance (e.g. lung volume). Although this is a viable argument,
measuring upper airway resistance throughout inspiration accurately reflects the impact of longterm facilitation on this variable.
Long-term facilitation of minute ventilation and its components
The results from the present study largely confirm our previous findings that exposure to
mild intermittent hypoxia induces long-term facilitation of minute ventilation during sleep.
Likewise, our results confirm that modulation of tidal volume was principally responsible for the
observed long-term facilitation. We were also interested in examining if long-term facilitation of
minute ventilation was modulated by the time of day. Previously we reported that the magnitude
of long-term facilitation during wakefulness was greater in the evening compared to the morning
in humans with obstructive sleep apnea. The mechanisms responsible for the diurnal variation in
ventilatory long-term facilitation remain to be determined. However, one intriguing possibility is
that evening to morning alterations in serotonin levels are responsible for our observations.
Serotonin is a neuromodulator required for the initiation of ventilatory long-term facilitation in
rats. Moreover, serotonergic levels vary between wakefulness and sleep, with levels being
higher during the former state. More importantly, the synthesis and release of serotonin via
adrenergic signaling in rats have been reported under constant lighting conditions, with peak
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levels occurring later in the day and decreased synthesis and release in the early morning.
Similar to the previous findings obtained during wakefulness we did observe differences in the
magnitude of long-term facilitation of minute ventilation and tidal volume in the evening
compared to the morning during sleep; although the magnitude of the difference was less during
sleep compared to wakefulness. The reason for this discrepant finding remains to be determined.
It is possible that the modulation of serotonin from the evening to the morning during sleep is not
as great compared to the ‘awake’ state. Alternatively, it is possible that the modulation from
evening to morning is significant enough to initiate differences but that the end-recovery time
employed in the present investigation was not sufficient to allow clear differences in magnitude
to manifest. More specifically it has been shown in animals including humans that long-term
facilitation tends to “wind-up” during the recovery period following exposure to intermittent
hypoxia. Typically this “wind-up” does not occur immediately at the onset of the recovery
period.

Consequently, because the end-recovery period was relatively short while the

participants were treated with therapeutic continuous positive airway pressure clear differences
in the magnitude of long-term facilitation between the evening and the morning might not have
manifested. This is a possibility given that evening to morning differences appeared to manifest
in measures of upper airway resistance (see below for additional details).
Impact of long-term facilitation on therapeutic positive airway pressure
As expected long-term facilitation of minute ventilation was accompanied by an increase
in inspiratory flow during end recovery following exposure to intermittent hypoxia while the
participants were treated with therapeutic continuous positive airway pressure. In contrast,
airflow remained at baseline levels following exposure to the sham protocols. The increase in
inspiratory flow could be the consequence of initiating long-term facilitation of upper airway
and/or phrenic motoneurons.

In regards to the testing of our primary hypothesis (see
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Introduction) we were interested in establishing if long-term facilitation of upper airway muscle
activity was initiated following exposure to intermittent hypoxia. To support this possibility we
examined changes in upper airway resistance after exposure to intermittent hypoxia. Moreover,
we determined if the upper airway was less collapsible by examining inspiratory airflow patterns
following reductions in positive airway pressure.

Our results showed that in addition to

increases in inspiratory flow, upper airway resistance was reduced compared to baseline
following exposure to intermittent hypoxia when the participants were treated with therapeutic
continuous positive airway pressure. This finding is similar to the results reported by Rowley
and colleagues. In contrast, upper airway resistance remained at baseline levels following
exposure to the sham protocol. Moreover, when the positive airway pressure was reduced by 5
cmH2O inspiratory airflow and resistance remained unaffected following exposure to intermittent
hypoxia.

These findings suggest that both upper airway collapsibility and resistance are

impacted by exposure to mild intermittent hypoxia. Our results are in contrast to the findings of
Rowley and colleagues who reported that upper airway collapsibility remained unaltered despite
decreases in upper airway resistance following exposure to intermittent hypoxia (Rowley et al.,
2007).

We also showed that inspiratory airflow was limited and upper airway resistance

increased when the positive airway pressure was reduced by 5 cm H2O following exposure to the
sham protocol. Similarly although reductions in flow and increases in upper airway resistance
were evident after the positive airway pressure was reduced by 7 cm H2O following exposure to
intermittent hypoxia the changes observed far exceeded the modifications in inspiratory flow and
upper airway resistance when the positive airway pressure was reduced by a similar amount after
exposure to the sham protocol.
The inspiratory flow modifications observed during end recovery in response to treatment
with the therapeutic pressure or thereafter when the positive airway pressure was reduced were
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similar in the evening compared to the morning. This findings suggests the magnitude of longterm facilitation of upper airway muscle activity or lack thereof (i.e. sham protocol) was not
modulated by the time of day. Alternatively, increases in upper airway resistance were greater in
the morning compared to the evening when the positive airway pressure was reduced by 5 and 7
cm H2O following the sham protocol, indicating the possibility that long-term facilitation might
be modulated by time of day.
The inspiratory airflow patterns observed following the sham protocol also indicated that
time of day had no impact on upper airway collapsibility. This latter finding does not support
our previous results which showed that collapsibility of the upper airway was greater in the
morning compared to the evening. Likewise, it is counter to findings from the present study
which showed that the therapeutic pressure required to eliminate apneic events was greater in the
morning compared to the evening although admittedly the differences were not dramatic. Lastly,
following the sham protocol upper airway resistance was greater in the morning compared to the
evening after the positive airway pressure was reduced by 5 and 7 cm H2O.

Thus, the

preponderance of evidence suggests that factors influencing upper airway resistance and
collapsibility are likely impacted by the time of day.
Summary and conclusions
We have shown that exposure to mild intermittent hypoxia leads to the initiation of forms
of respiratory plasticity that are beneficial to improving upper airway patency. More specifically
we showed that following exposure to intermittent hypoxia continuous positive airway pressure
could be reduced by 5 cm H2O without impacting on inspiratory airflow and upper airway
resistance. We propose that exposure to intermittent hypoxia might serve as an adjunct therapy
to promote airway patency, which in turn could reduce the therapeutic pressure required to treat
sleep apnea and potentially improve treatment compliance leading to improved outcome
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measures. Likewise we propose that in addition to improving compliance mild intermittent
hypoxia might have a direct impact on a number of co-morbid conditions associated with sleep
apnea. Thus mild intermittent hypoxia could serve as a multi-pronged therapy to mitigate comorbidities associated with sleep apnea both directly and indirectly by improving treatment
compliance.
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CHAPTER 6 - CONCLUSION
We have shown in the 2 aims discussed throughout this dissertation that multiple
mechanisms involved in the control of breathing are indeed modulated in a circadian fashion,
resulting in increased sensitivity to blood gas fluctuations, decreased carbon dioxide reserve and
increased airway collapsibility. Those patterns were tightly correlated to with baseline carbon
dioxide levels, potentially connecting them to a plethora of metabolic and hormonal changes.
The subsequent breathing instability was evident in the observation that breathing events were
longer in duration in N1 and N2 stages of sleep, and more frequent in the N1 stage. Such
manifestation of the abovementioned patterns would have an impact on the treatment of
obstructive sleep apnea with continuous positive airway pressure, as well as the recommended
sleep scheduling and daytime naps. In addition, the therapeutic pressure required to eliminate
one's breathing events will be largely affected. Titrations are therefore often overestimating the
pressure for evening and afternoon sleep and/or underestimating it for morning sleep. Another
therapeutic benefit from these findings is the identification of the increased collapsibility and
chemoreflex sensitivity as potential pharmaceutical targets to mitigate the severity of OSA.
Given that a multitude of the discussed mechanisms is affected/modulated by serotonin,
we then investigated a potential circadian variation of the initiation and magnitude of respiratory
plasticity, in which serotonin is a key player. We were mainly interested in the long term
facilitation of upper airway muscle activity. The focus on that form of plasticity was catalyzed
by its importance in maintaining upper airway patency, and consequently affecting the TP.
Using intermittent hypoxia as a stimulus, we successfully initiated LTF of upper airway
muscles, as evident by the ability of the airway to maintain optimal airflow at lower pressures, as
well as a lack of resistance to that airflow. That effect was more maintainable in the evening
compared to the morning (mainly in terms of developing resistance). Such findings can have a
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big impact on OSA and CPAP therapy, one that has been largely marred by a low compliance
rate due to uncomfortably high pressures. Initiating upper airway LTF and decreasing TP has the
potential to revolutionize the approach to titration and CPAP prescription. IH, as an adjunct
treatment, could be computerized and incorporated into the CPAP technology, which, along with
the available auto-PAP abilities, might combine for a much more efficient and accurate way to
administer positive pressure hopefully leading to a higher compliance level and consequently
mitigating the severity of disorders caused by sleep apnea.
Finally, as we discussed in length in Chapter 5, IH in itself is garnering increasing
support and evidence to its potential as a therapeutic modality, exerting both indirect and direct
beneficial effects targeting many of the downstream co-morbidities of OSA, making it a multipronged therapeutic approach very worthy of further examination.
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Purpose:

Our project was designed to determine the effect of time of day on multiple

mechanisms influencing breathing stability and respiratory plasticity. We investigated if the
number and duration of breathing events coupled to upper airway collapsibility, as well as the
carbon dioxide reserve, chemoreflex sensitivity and arousal threshold during non-rapid eye
movement (NREM) sleep were affected by the time of day. In addition, we examined if mild
intermittent hypoxia (IH) initiates long-term facilitation of upper airway muscle activity leading
to a reduction in the therapeutic continuous positive airway pressure required to eliminate
breathing events.
Methods: Male participants with obstructive sleep apnea completed a constant routine protocol
that consisted of sleep sessions in the evening (10 PM to 1 AM), morning (6 AM to 9 AM), and
afternoon (2 PM to 5 PM). On one occasion the number and duration of breathing events was
ascertained for each sleep session. For breathing events detected during these sessions the rate of
change of respiratory effort, maximum respiratory effort immediately prior to termination of an
event, and the maximum tidal volume and the minimum partial pressure of end-tidal carbon
dioxide (PETCO2) immediately following an event were measured. Participants then completed
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the same protocol on two additional occasions, where the critical closing pressure that
demarcated upper airway collapsibility was determined on one, and baseline levels of carbon
dioxide PET(CO2) and minute ventilation, as well as the PET(CO2) that demarcated the apneic
threshold and hypocapnic ventilatory response were measured on the other (the order of these 2
visits was randomized). In the second aim of the study, male participants with obstructive sleep
apnea were treated with twelve 2-minute episodes of hypoxia (PETO2 ≈ 50 mmHg) separated by
2-minute intervals of normoxia in the presence of PETCO2 that was sustained 3 mmHg above
baseline. During recovery from the last episode the positive airway pressure was reduced in a
step-wise fashion until flow limitation was evident. The participants also completed a sham
protocol under normocapnic conditions, which mimicked the timeframe of the IH protocol.
Results: The duration of breathing events was consistently greater in the morning compared
with the evening and afternoon during N1 and N2, while an increase in event frequency was
evident during N1. The critical closing pressure was increased in the morning (2.68 ± 0.98 cm
H2O) compared with the evening (1.29 ± 0.91 cm H2O; P ≤ 0.02) and afternoon (1.25 ± 0.79; P ≤
0.01). The increase in the critical closing pressure was correlated to the decrease in the baseline
partial pressure of carbon dioxide in the morning compared with the afternoon and evening (r =
−0.73, P ≤ 0.005). The nadir of core body temperature during sleep occurred in the morning and
was accompanied by reductions in minute ventilation and PETCO2 compared with the evening
and afternoon (minute ventilation: 5.3 ± 0.3 vs. 6.2 ± 0.2 vs. 6.1 ± 0.2 l/min, P < 0.02; PET(CO2):
39.7 ± 0.4 vs. 41.4 ± 0.6 vs. 40.4 ± 0.6 Torr, P < 0.02). The carbon dioxide reserve was reduced,
and the hypocapnic ventilatory response increased in the morning compared with the evening
and afternoon (carbon dioxide reserve: 2.1 ± 0.3 vs. 3.6 ± 0.5 vs. 3.5 ± 0.3 Torr, P < 0.002;
hypocapnic ventilatory response: 2.3 ± 0.3 vs. 1.6 ± 0.2 vs. 1.8 ± 0.2 l·min(-1)·mmHg(-1), P <
0.001). The rate of change of respiratory effort was similar in N2 compared to N1 but the
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maximum respiratory effort immediately prior to event termination was greater (-10.7 ± 1.2 vs. 9.6 ± 1.0 cm H2O/s, P < 0.05). Likewise, tidal volume was increased (1169 ± 105 vs. 1082 ±
100 ml, P < 0.05) and PETCO2 was decreased (37.0 ± 0.8 vs. 37.7 ± 0.8 mmHg P < 0.05)
following events in N2 compared to N1. A similar tidal volume and PETCO2 response was
evident following events in the morning compared to the evening independent of sleep stage.
After exposure to IH the therapeutic pressure was significantly reduced (Δ CPAP = - 4.95 ± 0.5
cmH2O, p < 0.001) without evidence of flow limitation (P > 0.2) or increases in upper airway
resistance (P > 0.4). In contrast, a similar decrease in pressure was accompanied by significant
flow limitation (P < 0.003) and an increase in upper airway resistance (P < 0.01) following
completion of the sham protocol.
Conclusion: Our findings indicate that time of day affects the duration and frequency of events,
coupled with alterations in upper airway collapsibility and chemoreflex properties during sleep,
which may contribute to increases in breathing instability in the morning compared with other
periods throughout the day/night cycle in individuals with sleep apnea.

We propose that

increases in airway collapsibility in the morning may be linked to an endogenous modulation of
baseline carbon dioxide levels and chemoreflex sensitivity, which are independent of the
consequences of sleep apnea.

We also conclude that alterations in the arousal threshold,

reflected by an increase in respiratory effort at event termination, coupled to increases in tidal
volume and reductions in PETCO2 contribute to modifications in event duration and frequency
associated with variations in sleep state or time of night. In addition, exposure to IH decreases
the therapeutic pressure required to eliminate apneic events which could improve treatment
compliance. This possibility coupled with the direct beneficial effects of IH on co-morbidities
linked to sleep apnea suggests that IH may have a multipronged therapeutic effect on sleep
apnea.
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